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INTRODUCTION. 
The importance of acute lobar pneumonia and the need for means 
to prevent its ravages are now generally recognized. Among the 
infectious diseases pneumonia ranks next to tuberculosis as a cause 
of death, and in many of our large cities it kills more persons each 
year than does tuberculosis itself. In the public mind pneumonia 
is generally thought to affect mainly the very young and the old and 
decrepit. As a matter of fact, over half the cases occur between the 
ages of 20 and 50, during the period of greatest activity. 
Although it occurs chiefly in endemic form, small and even large 
epidemics are not unk.11:own. It was the most serious disease which 
threatened the success of construction of th'e Panama Canal, and its 
prevalence in certain regions where large numbers of susceptible 
workers·are brought together, as in the mines of South Africa, renders 
it of great economic importance. Its importance as a cause of sick­
ness and death among soldiers is not generally recognized, at least 
in this country, in spite of the fact that in our CivH War, aside from 
- dysentery and typhoid, it caused far more deaths th� any other
disease. With improvements in knowledge of preventing and treat­
ing the two former diseases, pneumonia bids fair in the present war
to lead all diseases as a cause of death. Judging from the experience
in European armies, both in times of war and in times of peace 1 
pneumonia is especially likely to attack raw recruits. The experi­
ence among the small number of troops o� the Mexican Border,
where pneumonia occurred in epidemic form, should be a warning
of what is likely to happen in our national army when large num­
bers of susceptible men are brought together during the winter
months.
Up to a few years ago the problem of preventing the spread of
pneumonia or reducing its destructive effects seemed almost hopeless.
The fact that bacteria apparently identical with those causing pneu­
monia are found in the mouths of many normal persons seemed
to render any proposed measures for the prevention of infection well-' 
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nigh useless. Attempts to cure the disease by the serum of immune 
animals had also given very incon,clusive or negative results. 
During recent years there has been in progress in the Hospital of 
The Rockefeller Institute a study of acute lobar pneumonia with the 
special object of improving methods of treatment. Realizing that 
such improvements are most likely to follow increase in knowledge 
of the pathogenesis of the disease and especially knowledge concern­
ing the etiologic agent itself, much time has been given to the study 
of the pneumococcus, to the study of its distribution, which is 
so necessary for a knowledge of the epidemiology of the disease, 
and especially to a study of its immunity reactions, in order that 
methods for specific treatment might be obtained. As a result 
of this study, certain observations have been made and methods 
have been devised whiqr have a direct practical bearing upon diag­
nosis ahd treatment. These observations have been published from 
time to time in papers appearing in The Journal of Experimental
Medicine and elsewhere. At the present time of emergency and 
stress, however, it seems desirable that whatever is of _practical 
value in this work should be made easily accessible, and, with the hope 
of meeting this need, this monograph has been prepared. 
In the studies which have been carried on at the Hospital of The 
Rockefeller Institute, attention has been confined to pneumoni3: of 
the lobar type, due to Diplococcus pneumoni�, though certain of the 
results obtained are undoubtedly applicable to lobular infections of 
the lung and to other pneumococcus infections as well. It is our 
'purpose here, however, to consider only the application of bacterio­
logic and immunologic facts to the fo�er disease. 
It is not intended . to present a complete description of this dis­
ease, the clinical features of which are well known. A brief general 
review of the bacteriology of pneurnococcus, however, is included; 
but no attempt· has· been made to present a complete review of the 
entire subject. Much work which is undoubtedly important has not 
been discussed, and the writers have aimed chiefly to present the re­
sults of their own work and that of their associates in The Rocke­
feller Institute, and to describe the technique that has been there 
developed in the etiologic diagnosis an4 specific. treatment of this 
disease. It is hoped that this monograph may be of aid to the 
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worker in the clinical laboratory who assists in diagnosis, to the 
public health worker who is attempting preventive measures, to the 
manufacturer who prepares immune serum, and to the clinician who 
carries out specific treatment. To meet all these requirements in a 
small space has demanded that the material be very much condensed 
and that, as far as possible, theoretic discussions be omitted. On 
the other hand, the effort has been made to describe method� accu­
rately and with considerable attention to detail, in order that they 
may be employed even by those without very extensive bacteriologic 
training. It has been thought best to err on the side of too minute 
description of details and, in many cases, technical descriptions of. 
very simple procedures, that are undoubtedly quite familiar to trained 
laboratory workers, are included. 
The problems concerning pneumonia which remain to be solved are 
numerous, and the difficulties of successfully applying serum treat­
ment to _all forms of pneumonia still seem almost unsurmountable. 
Nevertheless, we now possess considerable knowledge concerning 
the mod� of spread of the disease, more knowledge indeed than we 
have of some other diseases that are thought preventable, and we 
have perfected methods for successfully treating at least a part of the 
cases. We believe that there exists at present not only the.justi­
fication for, but also the duty of attempting to apply these facts on a 
-larger scale, especially at this time when special danger threatens a
large part of our most valuable population, and when it is so impor­
tant that human life be conserved. The application of these facts,
however, cannot be effectively made in a crude haphazard manner.
Sufficient supplies of serum of standard potency must be available
and public health laboratories, hospital laboratories, and army field
hospital laboratories must be equipped to carry out the necessary
procedures. In addition, there is needed a very close cooperation
·between the laboratory workers and those actually engaged in the
care of patients, and the latter, as well as the laboratory workers,
should have knowledge of the principles concerned and of the lab-
oratory methods employed.
DEFINITION AND ETIOLOGY. 
Acute lobar pneumonia is an acute infectious disease, the character­
istic pathologic feature of which is a uniformly diffuse,  exudative 
inflammation of entire portions of one or more lobes of the lung. 
It has long been a question of dispute, however, whether the defini­
tion of the disease shall be based on pathologic, etiologic, or clinical 
features. In our opinion, as far as prevention and cure of the dis­
ease are concerned, it is of the greatest importance that the chief 
stress should be laid on the etiologic agent. Lobar inflammation 
of the lung may undoubtedly be caused by a number of different -
bacteria. The vast majority of the lesions, however, are caused 
by varieties of Diplococcus pneumoni(JJ. Among 529 cases diag­
nosed from the clinical and pathologic features as acute lobar pneu­
monia, the following were the etiologic agents concerned: 
' 
Diplococcus pneitmonire . ................ , . . . . . . . . . . . . . . . . . . . . . 454 
Friedllnder's bacillus... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
Bacillus infiuenzre. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 
Streptococcus pyagenes .. _ .. _ ..... �. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 
Streptococcus mucosus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
Staphylococcus aureus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
fases of mixed inf�tion with combinations of Staphylococcus aureus, 
Friedliinder's bacillus, B. infiuenzre, Streptococcm pyogenes, and 
Streptocaccus viridans. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 
Undetermined (most of them occurring before accurate methods for 
determining the etiologic agent had been devised) . . . . . . . . . . . . 49 
Total. .................................. .................. 529 
It is not important to discuss here whether the pulmonary lesions 
due to Diplococcus pneumoni(JJ are. identical with those produced by 
other microorganisms. In typical cases, possibly in all, differences 
are present. At the present time, however, the differences in 
lesions ·cannot be detected with certainty during the life of the pa­
tient. The cases due to different varieties ·of bacteria are clinically 
indistinguishable, though the typical cases due to certain organisms 
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may present certain fairly characteristic features. With further 
study of large_ series of cases in which the etiologic agent in the in­
dividual case is carefully determined, it may be possible to devise 
methods for making a diff erentia1 diagnosis on clinical groµnds. At 
present we must rely on the isolation and identification of the or­
gan:ism concerned in each individual case. While we recognize, 
therefore, that lobar pneumonia may be due to a number of different 
organisms, in our present study we prefer to 1imit the discussion to 
that form due to Diplococcus pneumonire. As will be shown later, 
all pneumococci are not identical, but may be differentiated into sev­
eral different types. This fact is of fundamental importance- in all 
that concerns prevention and treatment of this disease, and, there­
fore, we believe that from the clinical standpoint, as well as from 
the bacteriologic, the cases due to the different types of pneumococci, 
as well as those due to other varieties of bacteria, should be consid­
ered distinct clinical entities. Instead of considering lobar pneu­
monia one disease, we should consider it a group of diseases. At 
present we can distinguish no constant clinical or pathologic differ­
ences among the cases due to the different types of pneumococci, 
though certain observations suggest that a clinical differentiation, 
even of these cases, may not be entirely impossible. Such a separa­
tion of the cases of pneumonia is entirely analogous to what we have 
become accustomed to in the typhoid-paratyphoid group of infec­
tions. Clinically all the cases due to this entire group of organisms 
are very similar. Their differentiation, however, has become neces­
sary for epidemiologic and therapeutic reasons. It is true that the 
different types of organisms in the enteric group possess slight cul­
tural differences in addition to immunologic ones, while the different 
types of pneumococci differ from each other, as far as we can de-
. tect at present, almost entirely in their immunity reactions. These 
latter differences, however, from the standpoint of prophylaxis and 
treatment, are much more important than cultural distinctiqns. 
DIPLOCOCCUS PNEUMONUE . 
.In 1881 Pasteur (21) described an organism, recovered from the saliva of a 
case of rabies, which produced a fatal septicemia in rabbits and which he desig­
nated microbe septicemique du salive. Almost synchronously, but quite inde­
pendently, Sternberg (27) in this country reported the occurrence of a similar 
coccus in the saliva of healthy individuals. The microorganism described by 
these two investigators is now recognized as pneumococcus, or Diplococcus 
pneumonire. At the time these observations were made, however, the pneu­
mococcus was not known to be associated with disease in man. It was not, 
until the systematic investigations of Fraenkel (4) several years later (1884-85) 
on the e..tiology of pneumonia, and the report of W eichsel.baum (34) on the 
occurrence of the pneumococcus in the blood, organs, and exudates of a large 
series of cases of this disease, that the causal relationship of this organism to 
lobar pneumonia was established. 
The original discovery of pneurnococcus in the saliva of healthy 
individuals, and the later investigations which proved this same 
organism to be associated with one of the most fatal of the acute 
infectious diseases in man, forecast the wide distribution which this 
organism is now known to possess: The fact that pneumococcus may 
vegeta�e as a harmless saprophyte in the mouth secretions of normal 
persons, and that this same organism may give rise to severe and 
fatal infections in man is also foretold in the early history of its dis­
covery." Subsequent work by numerous investigators has abundantly 
con:firmed this curious paradox, but the faterpretation of its signifi­
cance in the epidemiology and specific therapy of pneumonia has been 
made possible only by the recognition of the biologic relationships of 
pneumococci by means of immunity reactions. 
Morphology and Cultural and Other Biologic Characteristics. 
M orphology.-Pneumococcus is a Gram-positive coccus which in 
the exudates of infected animals and on artificial media is typically a 
lance-shaped diplococcus. Variations in the size and form of the 
cocci may be noticed, however, in different cultures and even in the 
individual organisms present in the sam� culture. Oval, round, and 
9 
10 ACUTE LOBAR PNEUMONIA 
elongated bacillary forms may occur. In young, actively growing 
broth cultures of pneumococcus, ch?,in formation is common, while in 
the same culture, after 18 hours' incubation, the organisms are usu­
ally arranged in pairs with only an occasional short chain. In older 
cultures of pneumoco'ccus, the organisms often appear Gram-negative, 
swollen, with degenerated and involuted forms, resulting from disin­
tegration and death of the cells. Pneumococcus is readily stained 
by all the usual aniline dyes. It possesses no flagella, is non-motile, 
and does not form spores. Capsules are easily demonstrable in 
animal exudates and, by appropriate methods, may be found in 
cultures from media enriched with blood or serum. The capsular 
substance is most marked in recently isolated virulent strains, and is 
readily lost on prolonged cultivation. In Pneumococcus mucosus,
Type III, the capsule is so pronounced as to be frequently demon­
strable by Gram's stain, by which method it appears as a negatively 
staining halo about the Gram-positive cell body. The exact signifi­
cance of the capsule of pneumococcus is not known. That it may 
serve as a protective mechanism of the organism and that it may in 
some way be related to virulence, is suggested by the fact that cap­
sular development is always much more marked when the organism 
is grown in animal tissues in which presumptively there is some 
opposition to its development. Study of a large number of strains 
of pneumococci shows that there are average differences in capsular 
development between Types I, II,.III, and IV (page 17). Although 
in some strains of Type IV pneumococci capsular formation is well 
marked, in others it is quite irregular and at times impossible to 
demonstrate, even under the most favorable conditions. Type I 
pneumococci usually show well formed capsules, and in Type II pneu­
mococci the capsules are quite easily demonstrable and are generally 
somewhat larger and den;;er than in Type I. In Type III pneumo­
cocci capsules are always well developed, are very large in compari­
son with the size of the organisms, and may appear as voh.;minous 
envelopes about the cell bodies. In our experience the amount of 
capsular development seems to parallel the virulence of these organ­
isms for man, as measured by the mortality occasioned by the dif­
ferent types in human infectioj, In addition, it seems to be true 
that the greater the amount of capsular development, the less the 
amount ?f passive protection afforded by immune serum. 
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Cultural Characteristics.-While growth may be obtained on the 
usual simple media, pneumococcus is, nevertheless, sensitive to 
slight variation in composition and reaction of the media. On media 
prepared from meat extract, growth is irregular and at best sparse 
and delicate. The pneumococcus colony on the surface of meat in­
fusion agar, which has been enriched by the addition of a small 
amount of sterile de:fibrinated rabbit blood, presents certain charac­
teristic features. The colony is small, moist, translucent, discrete, 
and round, with well defined edges, greenish in color, with a checker­
like or ringed topography. The colony is finely granular, with a 
darker center, surrounded by lighter ringed areas. Pneumococcus 
on blood media produces a greenish zone of discoloration about the 
colonies. 
In broth pneumococcus grows diffusely, producing a uniform tur­
bidity without pellicle and with a slight flocculent sediment. The 
turbidity of broth cultures begins to clear up af�er 24 hours' incuba­
tion, corresponding to the period of beginning autolysis and the 
passing into solution of the disintegrating bacterial protein. 
Gelatin is not liquefied; this medium, however, is not well adapted 
for the cultivation of pneumococcus, since no growth of this organism 
occurs at temperatures below 25°C. 
In milk and inulin serum water pneumococcus produces acid and 
coagulation of the medium. Inulin fermentation by pneumococcus 
is of differential value in distinguishing this organism from strepto­
coccus. In studying the fermentation of inulin by pneurnococcus, 
various irregularities are encountered. Although fermentation-is the 
rule, it is not uncommon to find stra4ts that fail to ferment this 
carbohydrate, and, in addition, the same strain may ferment it at 
one time, and fail to ferment it at another. The failure to ferment 
inulin in many instances may be due to the fact that not all prepara'­
tions of inulin are fermentable by pneurnococcus, and not infrequently 
different lots of media, prepared fr9m the same inulin, vary in their 
suitability for growth. Therefore, while inulin fermentation is of 
value in differential diagnosis of pneumococcus from other organ­
isms, this reaction should be considered only as confirmatory evidence. 
The addition pf simple carbohydrates to culture media enhances 
the initial growth ,o( pneumococcus. However, the amount of acid 
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formed by pneumococcus in sugar-containing media quickly reaches 
a point at which growth is inhibited and the organisms rapidly die 
in the products of their own metabolism. Fermentativ� reactions of 
certain bacteria on selective carbohydrate have, in some instances, 
furnished a basis for differential classification. A study of a large 
number of strains of pneumococcus of known types on a series of 
different carbohydrates has so far failed to show any fermentative 
reaction which would afford a biochemic differentiation corresponding 
to the immunologic classification of the four types of pneumococcus. 
Temperat,u,re and Oxygen Requirements.-Pneumococcus is not sen­
sitive in its oxygen requirement, and growth occurs equally weJl 
under aerobic and anaerobic conditions. The optimum temperature 
for cultivation is 37°C., the limits of temperature range being 25-
410C. The thermal death-point of pneumococcus as determined by 
Sternberg is 52°C. for 10 minutes. The viability of pneumococcus on 
artificial media is relatively short. It has long been a matter of com­
ment that even on suitable meclium of proper reaction pneumococcus 
sometimes fails to grow. This is especially common when an attempt 
is made to grow the pneumococcus in meat infusion broth. Jn making 
transfers from broth to broth it is usually necessary to increase the 
amount of inoculum in proportion to the amount of broth in which 
the organism is to be grown (R36) .1 The usual amount of culture 
that it is ne�essary to transfer in order to insure growth is about 0.1 
cc. to 5 cc. of broth. It is usually easy to start growth in broth if
the inoculation is made from infected blood. A loop of heart's blood
of a mouse dead of pneumococcus septicemia often suffices to initiate
growth in large amounts of broth, and always succeeds in amounts of
5 to 25 cc. of the 'U].edium. On the other hand, the transfer from
broth to broth of pneumococcus recently isolated is more difficult
and usually requires a considerably larger inoculation. As a strain
becomes accustomed to growth in broth, reinoculations into this me­
dium grow with more regularity, although always requiring the
relatively large inoculum already referred to. Chesney (2) has shown
that transfers of pneumococcus made during the period of maximum
rate of growth grow readi]y and without the latent period of de-
1 R before reference numbers indicates that th� title appears among the 
papers by the Staff of the Hospital of The Rockefeller Institute (page 106). 
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veloprnent which is characteristic of older cultures. Kirkbride (6) 
has further shown that when transfers in broth are made at 8 hour · 
intervals, pneumococcus maintains its· animal virulence for long 
periods of time, whereas cultures'made at 24 hour periods rapidly lose 
their virulence. 
Viability.-The addition of defi.brinated.rabbjt blood to media not 
only enhances the growth of pneumococcus, but prolongs the life of 
the culture. Cultures of pneumococcus in blood broth preserved in 
the ice box remain viable for several weeks. One of the best methods 
for preserving pneumococcus cultures is that devised by Heim (5), 
by storing the dried spleens of infected mice. At the time of autopsy 
the spleen of the infected mouse is . removed and transferred to a 
small sterile glass tube. The infected organ is quickly dried in 
vacuum and the desiccated tissue kept sealed in the cold, unexposed 
to light. Pneumococcus thus preserved maintains its viability and 
virulence for months. The culture may be recovered by grinding up 
the desiccated spleen in a sterile mortar with a little broth and in­
jecting the organ emulsion intraperitoneally into a mouse, from 
which the pneumococcus can in turn be recovered in culture. In 
selecting spleens for preservation, care should be taken to choose 
those from animals in which no mouse typhoid infection exists. 
Mouse typhoid is a common infection in mice, frequently responsible 
for the death of large numbers when it becomes widespread. Mice 
which are apparently healthy frequently carry the bacillus of mouse 
typhoid in the intestine, and when· these animals are experimentally 
infected with pneumococcus, the typhoid organism becomes active 
and invades the blood, tissues, and body cavities. It is difficult to 
obtain pure cultures of pneumococcus from such mice because of the 
rapidity and vigor with which Bacillus typhi murium grows on arti­
ficial media, and because of its great virulence for these animals. 
Bile Reaction.-Neufeld (13) first observed the fact that pneumo­
coccus in the presence of bile und,ergoes solution. Bile solubility is 
now recognized as a ·distinctive biologic character of pneumococ'cus, 
and serves to differentiate it from closely allied organisms, such as 
streptococcus. The active substance responsible for the lytic action 
of bile on pneumococcus is cholic acid. In carrying out the test, 
whole bile or 10 per cent solution of so�um taurocholate or sodium 
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glycocholate in physiologic salt solution may be used.1 One-fifth to
one-tenth volume of bile will cause solution of an actively growing 
broth culture of pneumococcus. Heat-killed pneumococci lose their 
bile solubility. The presence of serwn in pneumococcus cultures 
inhibits or completely arrests the lytic action of bile. Neufeld 
reports the insolubility of certain avirulent strains of pneumococcus. 
This phenomenon of insolubility, however, must be comparatively 
rare, since among several hundred strains of pneumococcus isolated 
by us from lobar pnewnonia, none has failed to be dissolved by bile. 
In the diagnosis, then, of virulent pneumococcus, considerable reliance 
may be placed on the bile reaction. 
Virulence. -The virulence of pneumococcus is variable; it is attenu­
ated by prolonged cultivation on artificial media, and increased by 
animal passage. The virulence of pneumococcus for one animal 
species does not necessarily imply similar invasiveness for the 
tissues of another. Pneumococcus recovered from lesions in man 
does not invariably possess increased virulence for susceptible ani­
mals. Pneumococci isolated from the blood of pneumonia patients, as 
a rule, are of such virulence that 0.000001 cc. of broth culture kills 
white mice in less than 36 hours. On the other hand, strains have 
been recovered from the same source which possess only moderate 
virulence, faili� to kill white mice in much larger doses. The study 
of the virulence of pneumococcus isolated from the circulating blood 
during lobar pneumonia indicates that in general the intoxication is 
more severe and the prognosis graver, the greater the virulence of the 
infecting pneumococcus. Sip.ce, however, virulence can only be ex­
perimentally tested in a different species, and since the defensive 
mechanism of the host is variable, no direct measure of virulence in 
man is available. However, as will be shown later in the discussion 
of the biologic types of pneumococci, infection with pneumococci of 
the various types results in differences in mortality which are fairly 
constant. 
In addition to pneumonia, pneumococcus may give rise to inflam­
mation of the upper respiratory tract and the accessory sinuses of the 
nose. Infection of the middle ear and invasion of the meninges may 
also be due to pneumococcus. Primary peritonitis of pneumococcus 
origin may occur, especially in young children. Focal infections, as 
AVERY, CHICKERING, COLE, AND DOCHEZ 
. . 
15 
empyema, peritonitis, pericarditis, endocarditis, arthritis, and lung 
abscess due to pneumococci, may occur as sequelre of pneumonia. 
Toxin Production.-Pneumococcus is a highly pathogenic micro­
organism which is not known to secrete a soluble toxin, and whose 
harmful effects are supposed to be due either to the setting free of 
intracellul�r toxins, or to toxic split products formed by the disinte­
gration of bacterial protein (R28), or possibly directly to the meta­
bolic activities of the bacteria themselves (R29). When the bodies 
of pneumococci are dissolved either by the action of bile salts, autoly­
sis, or by alternate freezing and thawing, the resulting bacterial solu­
tion is actively hemolytic for red blood corpuscles and is acutely 
toxic for animals (R18, R23). Intravenous injection of such solp.tions 
of pneumococcus produces death in rabbits and guinea pigs with acute 
symptoms resembling those of anaphylactic death. The hemolytic 
substance is thermolabile•and its activity is lost by passage through a 
Berkefeld filter, and destroyed by proteolytic digestion with trypsin. 
Both the hemolytic and toxic properties of this substance are influ­
enced by the same measures, and the potency of both is to some 
degree dependent upon the virulence of the pneumococcus f�om 
which the substance is derived. The lytic action of the hemotoxin, as 
well as its harmful effects in animals, may be inhibited by cholesterol 
and partially neutralized by immune serum. Neutralization by anti­
pneumococcic serum, however, is incomplete and not strictly specific. 
Pneumococcus hemotoxin is not simply a product of autolysis, but 
undoubtedly exists preformed in the bacterial cell as a hemolytic 
endotoxin. 
The production of methemoglobin by pneumococcus is another 
phenomenon the occurrence of which may in some way be concerned 
with the harm£ ul effect of this organism in disease. The transfor­
mation of hemoglobin into methemoglobin by pneumococcus occurs 
only in the presence of free oxygen and the living bacterial cell. 
Culture filtrates. and bacterial extracts of pneumococcus, when free 
from living organisms, do not induce the methemoglobin reaction. 
Precipitable Substance (R6, R7).-Pneumococcus during the early 
stages of its growth forms a readily soluble substance which diffuses 
into the culture medium in vitro, and in human and animal infections 
is present in the �irculating blood, whence it passes through the kid-
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neys into the urine. This specific substance appears in the culture 
medium in considerable amounts as soon as the pneumococci start 
to grow. Its early presence is not attributable to the death and 
subsequent disintegration of the bacterial cell, but it is due to the 
extrusion into the medium of bacterial substance during the life 
processes of the organism. 
One of the chief points of interest in the discovery of the soluble 
substance of pneumococcus is that it raises the question whether 
this substance is in any way responsible for the intoxication which 
attends pneumococcus infection. Studies to ascertain the answer 
to this question are being carried on at the present time, but have 
not y.et progressed to the point at which a definite answer can be 
given. It may be said, however, that its toxicity is in no way com­
parable with that of diphtheria toxin. On the other hand, it possesses 
a degree of toxicity which, exhibited throughout the course of an in­
fection, might account for the signs of intoxication in lobar pneumonia. 
Differential Diagnosis. 
' Although a differential diagnosis is not always simple, pneumococcus 
possesses certain cardinal characteristics by virtue of which, in most 
instances, it may be readily distinguished from closely allied organ­
isms, as streptococcus. Pneumococcus is bile-soluble, possesses a 
capsule, ferments inulin, is extremely pathogenic for mice, and on 
blood agar forms a small, moist, fl.at, ringed, checker-like colony 
with a greenish zone of methemoglobin about it. Moreover, as will 
be discussed later, the various types of pneumococci react specifically 
with their homologous immune sera. Streptococcus, on the other 
hand, is not bile-soluble, does not ferment inulin, is less virulent for 
mice; on blood media the colony is more opaque and raised, drier, 
and more coarsely granular, without the surface markings or ringed 
topography characteristic of pneumococcus, and is surrounded by a 
zone of either hemolysis or green pigmentation. 
Considerable confusion still exists in bacteriologic literature re­
garding the identity of so called Pneumococcus muc.osus and Strepto­
coccus mucosus. Pneumococcus mucosus, or Type III pneumococcus, 
possesses the characteristics already described as typical of pneumo­
coccus; it is bile-soluble, ferments inulin, possesses a voluminous cap-
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sule, is extremely virulent for mice, and produces greenish discolora­
tion of blood media. Streptococcus m.ucosus, on the other hand, while 
having a similar mucoid, heaped up, confluent colony, and possessing 
a capsule, is, however, not bile-soluble, does not split inulin, is not 
so pathogenic for mice, and has a greater tendency to produce hemo­
lysis on blood agar. Finally, this organism, like other streptococci, 
does not react specifically with Antipneumococcic Serum Type III. 
Biologic Classification. 
With recent advances in bacteriology and the knowledge gained 
from attempts to apply the principles of bacterial immunity to human 
disease has come the recognition of the fact that, in addition to the 
grosser classification of bacteria, certain :finer characteristics exist 
which serve to differentiate still further members of the same bac­
terial species. Through the work of Neufeld (16) and his asso­
ciates, it was demonstrated that all races of pneumococci are not 
identical as far as their immunologic reactions are concerned. When 
the study of pneumonia at the Hospital of The Rockefeller Institute 
was undertaken, a large number of races of pneumococci from cases 
of pneumonia was isolated and the immune reactions of these were 
carefully studied (R33, R.20, R35). Animals were immunized to each 
of these strains, and the immunity reactions of all of them to the 
various immune sera so obtained were studied. Not only was th€ 
agglutinability of the various races in each of the sera determined, 
but also the power of each of the sera to protect mice from infection 
with each of the strains. The results of these studies revealed the in­
teresting fact that pneumococci fall into two general classes. The 
larger of these consists of pneumococci of Types I, II, and III, which 
comprise about 80 per cent of aH strains encountered in disease, and 
which represent three apparently fixed types ot' highly parasitic or­
ganisms, each possessing common in,imunologic characters. Indi­
vidual strains �f Type I and Type II are characterized by the pos­
session of i�unity reactions common to all other members of the 
homologous group. A number of variants of Type II pneumococcus 
have been found (R4), a condition of considerable theoretic interest, 
the practical importan9e of which, however, is not sufficiently great 
to warrant detailed discussion here. Type III consists of Pneumo-
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coccus mucosus, an organism distinguished from other types by mor­
phologic and cultural, as well as immunologic differences,, and related 
to other strains of the same type by common immunologic reactions 
(R38). 
The smaller of these two main classes, which has been called Type 
IV, represents about 20 per cent of the strains isolated from cases of 
lobar pneumonia, and is the type most frequently encountered in 
the mouth secretions of normal individuals. Type IV pneumococci 
possess greater heterogeneity and consist for the most part of indi­
vidual strains which are not interrelated. As originally described, 
this group was considered peculiar in that it seemed to comprise a 
heterogeneous series of independent varieties, none of which ex­
hibited immunity reactions common to the other types or to each 
other. However, more recent study by Olmstead (19) of a large series 
of strains of Pneumococcus Type IV has shown that this group may 
contain smaller groups, the members of each one of which possess 
certain characteristic immunologic properties. These studies of 
Type IV pneumococcus are of interest and the results hold promise 
of practical application. At present, however, the work has not 
progressed to a point where practical use of it can be made, and hence 
it would be premature to discuss this group from the standpoint of 
specific therapy. 
TABLE I. 




















*The incidence of atypical Type II pneumococci has been determined only
during the last 2 years. 
From Table I it is evident that Pneumococcus Type I is the most 
common cause of infection in man, giving rise to about one-third of 
the cases. Type II is next in frequency, and these two types together 
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give rise to over 60 per cent of cases of lobar pneumonia, at least in 
those localities in the United· States �n which studies of types of pneu­
mococcus have �een made. Pneumococcus mucosus (Type III) gives 
the lowest incidence in disease of the different types of pneumococcus. 
Type IV is responsible for about 20 per cent of cases, although the 
incidence of cases due to this organism seems to vary somewhat in 
different localities. 
The accuracy with which these types may be differentiated and 
the constancy of their relative frequency in disease and health em­
phasize the importance of their recognition in clinical and epi­
demiologic studies. The exactness with which the large number of 
strains studied has conformed to type indicates the extraordinary 
uniformity and comparative fixity of the specific groups. These 
distinctive differences in immunologic properties of pneumococcus 
not only offer a reliable method for the more exact determination of 
the. varieties of pneumococcus, but afford the only rational basis 
for the study of the epidemiology and immunotherapy of pneumococcal 
infections. 
Culture Media and Staining Methods. 
In the preparation of media suitable for growth of pneumococcus, 
attention should be paid to the following points: 
1. All media should be prepared directly from infusion of fresh
meat and not from beef extract. 
2. Reaction of the media should be from 0.3 to 0.5 ·acid to
phenolphthalein. 
3. In the sterilization of the media, care should be taken to avoid
excessive heating. Media should be �terilized by the Arnold method, 
20 minut�s on 3 successive days, andshould not be autoclaved. 
The following procedure has been found to give satisfactory results 
in the preparation of broth and agar for cultivation of pneumococcus: 
· Nutrient Broth and Agar.-1 pound 6£ lean chopped beef is allowed to infuse
in a liter of tap water over rught on ice. The unfiltered meat infusion is _boiled 
for 30 minutes, filtered through paper, and the loss by evaporation made up by 
the addition of water. 1 per cent peptone and 0.5 per cent sodium chloride are 
now added. 1.5 per cent agar may be added at this point if agar is desired. The 
mixture is allowed to boil for 2 minutes in the case of broth, or, if for agar, until 
the agar is dissolved. Titration to the neutral° point with normal sodium PY· 
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droxide is then carefully carried out. Media are then boiled for 6 or 7 minutes, 
made up to volume, and filtered clear, and sterilized in the Arnold sterilizer for 
20 minutes on 3 successive days. The media should finally titer 0.3 fo 0.5 acid 
to phenolphthalein. 
Blood Agar.-For enrichment purposes, the addition of a small amount of 
sterile defibrinated rabbit blood to media prepared as above is recommended. 
The addition of three or four drops of sterile blood to 4 or 5 cc. of agar or bouillon 
serves as ample enrichment and provides most suitable medium for the growth 
and preservation of pneumococcus cultures. Blood may be obtained either from 
the ear vein of a rabbit or by direct heart puncture. Drawn directly into a 
small sterile container with glass beads, the defibrinated blood can be preserved 
for a week or more, and the method is, therefore, economical. 
Serum Water Medium for Fermentation Tests.-For the· determination of 
inulin fermentation by pneumococcus, the following medium devised by Hiss is used, a positive reaction being indicated by the production of acid and the coagu­
lation of the serum protein. Clear beef serum is added to 2 or 3 vo]umes of 
distilled water. Heat the mixture for 15 minutes in an Arnold sterilizer at 
100°C. to destroy ferments present in the serum. Add 5 per cent aqueous litmus 
solution to a concentration of 1 per cent or an amount sufficient to give a deep 
blue color. Add inulin to the serum water to a concentration of 1 per cent. The 
inulin may be best sterilized by autoclaving at 15 pounds' pressure for 15 min­
utes. Sterilize the inulin serum water by the fractional method, 100°C. 
Preparation of Bile for Testing the Solubility of Pneumococcus.-Fresh ox bile, 
obtained directly from the slaughter house, is autoclaved for 20 minutes, at 15
pounds' pressure. The bile is filtered to remove 'the precipitate formed on heat­
ing and again autoclaved. The sterile bile is then ready for use. Heat does not 
destroy the Iytic action of bile. While different samples of bile vary in their con­
tent of the salts of cholic acid and hence in their ability to dissolve pneumococcus, 
for routine purposes the bile reaction may be carried out by the addition of one­
fifth to one-tenth volume of whole bile to plain broth culture of pneumococcus. 
Stains for Pneumococcus. Gram's Stain (Sterling's Modiftcation).­
Gentian violet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 gm. 
Alcohol, 95 per cent ....................................... 1 O cc. 
Aniline oil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 " 
Distilled water ............................................ 88 " 
The aniline oil and alcohol are mixed by shaking, and the distilled water is 
added. The genti� violet is ground in a mortar and the aniline solution 
added while grinding. The solution is stable 3 to 4 months and stains rapidly. 
Gram's Iodine Solution.-
Iodine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 gm. 
Potassium iodide. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 "
J?issolve in 20 cc. of distilled water. Add 300 cc. of distilled water. 
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Safranin Counterstain.-10 per cent aqueous solution of a saturated alcoholic 
solution of safranin. 
Hiss' Capsule Stain.-Preparations, are best made by direct films from 
pneumococcus exudates. Dry in air and fix by heat. Stain for a few seconds 
with saturated alcoholic solution of fuchsin or gentian violet, 5 cc., in distilled 
water, 95 cc. Flood the slide with the dye and hold the preparation for a 
second over a free :flame until it steams. Wash off the dye with 20 per cent 
aqueous copper sulfate solution. Blot; do not wash in water. 
By this method the capsule appears as a faint blue halo around a dark purple 
cell body. Better results may frequently be obtained by omitting heat fixation 
and by washing off the dye with the copper sulfate solution as soon as it begins 
to steam. Water should not be applied at any stage of the procedure. 
ETIOLOGIC DIAGNOSIS. 
If we possessed no methods for specific treatment or for instituting 
specific preventive measures, the determination of the etiologic agent 
in each individual case of lobar pneumonia would not be of great im­
portance. However, since it is now known that certain cases of 
pneumonia may be successfully treated with the serum of immune 
animals, provided that the organism used in preparing the serum is 
identical with that causing the infection, etiologic diagnosis becomes 
imperative. Practical and quite rapid methods have now been de­
vised for the detection of the organism causing the disease; even for 
the differentiation of the specific types of pneumococci. This etio­
logic diagnosis is, however, not only of importance in relation to 
serum therapy, but has an important bearing on prognosis and is 
essential for acquiring knowledge concerning the epidemiology of this 
disease. 
For the determination of the etiologic agent in cases due to other 
organisms than pneumococcus, the same general methods are applica­
ble as in cases due to pneumococcus. In certain cases, as those due 
to FriedHtnder's bacillus, streptococcus, or staphylococcus, the micro­
scopic examination of the sputum gives much information, and cul­
tures of the sputum made on agar plates may show a great predomi­
nance of the organisms causing the disease.. When the sputum from 
these cases is inoculated into a mouse, as in the method about to be 
described, these organisms outgrow the ordinary mouth saprophytes 
just as do pneumococci. Blood cultures from the patient, when 
positive, give, of course, clear evidence as to the nature of the 
infection. 
In the cases due to pneumococcus it is important not only to 
_ determine that the infection is due to this bacterium, but it is also of 
prime importance to determine the specific type of pneumococcus 
cau_sing the infection, since treatment with serum is only applicable 
in the cases due to Type I organisms. 
· · The following is a description of the various procedures employed
in the isolation of pneumococci and.determination of the specific types:
22 
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Isolation of Pneumococci. 
Organization of Laboratory.-In o,rder that these methods may be of,practical value, hospital and Board of Health laboratories should be 
so organized, if possible, that diagnoses can be made at any time, 
day or night. Arrangements for the rapid transmission of the speci­
men of sputum to the laboratory are of great importance, since the 
diagnosis must be made rapidly if the best results from serum therapy 
are to be obtained. After a moderate amount of experience by the 
laboratory worker, the method can be carried out with much rapidity, 
.. especially where a number of diagnoses are to be made at the same 
time; and where the work is properly organized, public health lab­
oratories should not find that the introduction of this procedure 
into their routine adds a great burden. For the actual carrying 
out of the procedure, the co�paratively simple equipment of any 
bacteriologic laboratory is sufficient. Facilities for the proper col­
lection and microscopic examination of sputum, together with means 
for its inoculation into mice, and the simple requirements for. mouse 
autopsy and bacterial cultivation are all the equipment necessary. 
Collection of Sputum.-Care should be exercised in the collection 
of sputum to obtain a specimen from the deeper air passages, as free 
as possible from saliva. This can be done in practically all cases, 
even the most difficult, with a ]itt]e persistence. The sputum is col­
lected in a sterile Esmarch dish, or other suitable container, and 
should be sent at once to the laboratory for examination. When 
delay is unavoidable, the specimen should be kept on ice during the 
interval. 
Microscopic Exq,mination of Sputum.-Direct films of sputum are 
stained by Gram, by Ziehl-Neelsen, and by Hiss capsule stains.· 
This serves to give an idea of the nature of the organisms present 
· and an indication of the source of the sputum. Suitable lung speci­
mens of sputum are relatively free, in most instances, from contami­
nating mouth organisms. It is frequently possible to identify Type
III (Pneumococcus mucosus) organisms when they are present, as
they possess very large, distinct capsules, staining by both Gram's
and Hiss' methods.
Mouse Inoculation.-A small portion of the sputum, about the size
of a bean, is selected and washed through three or four changes of
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sterile salt solution in sterile Esmarch or Petri dishes to remove sur­
face contaminations. When the sputum is too friable or when the 
specimen is relatively free from secondary organisms, �his washing 
process may be omitted. In either event, the kernel of sputum se­
lected is transferred to a sterile mortar, ground up, and emulsified 
with about 1 cc. of sterile bouillon or salt solution, added drop by 
drop, until a homogeneous emulsion is obtained that will readily pass 
through the needle of a small syringe. With a sterile syringe 0.5 to 
1 cc. of this emuls,ion is inoculated intraperitoneally into a white 
mouse (Figs. 1, 2, and 3). The pneumococcus grows rapidly in the 
mouse peritoneum, while the majority of other organisms rapidly die 
off, with the exception of Friedlander's bacillus, Bacillus influenz<.e, and 
occasionally Micrococcus catarrhalis, staphylococcus, and strepto­
coccus. Pneumococcal invasion of the blood stream also occurs early. 
Bacillus influenz<.e, if present, likewise invades the blood stream; 
other organisms, as a rule, do not. The time elapsing before there is 
sufficient growth of pneumococcus in the mouse peritoneum for the 
-satisfactory determination of type varies with the individual case,
depending upon the abundance of pneumococci in the specimen of
sputum and the virulence and invasiveness of the strain present.
It may be from 5 to 24 hours, averaging 6 to 8 hours with the para­
sitic fixed types I, II, and III. As soon as the injected mouse
appears sick, a drop of peritoneal exudate is removed by means of
peritoneal puncture with a sterile capillary pipette, spread on a slide
>
stained by Gram's method, and examined microscopically to deter­
mine whether there is an abundant growth of pneumococcus present.
If there is an abundant growth of pneumococcus alone
> 
the mouse is
killed and the determination of type proceeded with. If the growth
is only moderate, or if other organisms are present in any quantity,
further time must be allowed until subsequent examination of the·
peritoneal exudate shows an abundant growth of pneumococcus. It
should be emphasized that undue haste in killing the mouse is time
lost in the end.
Mouse Autopsy (Fig. 4).-As soon as the mouse is killed or dies,
the peritoneal cavity is opened with sterile precautions and cultures
are made from the exudate in plain broth and on one-half of a blood
agar plate. Films are made and stained for microscopic examination
by Gram's stain and Hiss' capsule stain. The peritoneal exudate
is then washed out by means of a sterile glass pipette with 4 to 5 cc.
of sterile salt solution, the washings being p]aced in a centrifuge tube.
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Cultures are then made from the heart's blood in plain broth and on 
the other half of the blood agar plate. 
Determination of Types of Pneumococcus. 
Agglutination Metltod.-When the pneumococcus is present in 
pure culture in the peritoneal exudate, the determination of type may 
satisfactorily be made by macroscopic agglutination tests, as follows: 
The peritoneal washings are centrifuged at low speed for a few min­
utes until the cells and fibrin contained in the exudate are thrown 
down. The supernatant bacterial suspension is transferred into a 
second centrifuge tube and centrifuged at high speed until the or­
ganisms are thrown out. The supernatant fluid is discarded and the 
bacterial sediment taken up in sufficient salt solution to make a 
moderately heavy suspension. The concentration of bacteria should 
be similar to that of a good 18 hour broth culture of pneumococcus. 
This suspension is used directly for macroscopic agglutination tests, 
being mixed with dilutions of immune serum in small test-tubes in 
equal quantities of 0.5 cc. each. 
To obviate the difficulty that occasionally arises from the occur­
rence of Type IV strains that show cross agglutination in all three 
immune sera, the optimum dilutions of serum and the optimum in­
cubation time that will surely identify all type strains and fail to give 
any cross agglutination reactions, have been determined on a large 
series of strains.2 The results are shown in Table IL 
TABLE II. 
Determination of Pneumococcus Types by Agglutination. 
Serum I Serum lI Serum II Serum III Poeumococcus (1: 20) (undiluted) (1 :20) (1 :S) suspension O .5 cc. o.s cc. 0.5 cc. 0.5 cc. 0.5 CC, 
Type I. ........ ......... ····· ++ - - -,, II. ..................... - ++ ++ -
Subgroups Ila, b, x ............ - + - -
Type III ..................... - - - ++ 
" IV ..................... - - - -, 
Incubation for 1 hour at 37°C. 
2 The dilutions of immune �erum indicated in both· the agglutinin and pre­
cipitin tests refer only to the antipneumococcic serum in u_se a� the Ho�p�tal ofThe Rockefcller Institute. As various lots of serum may differ m agglutmm and 
precipitin content, the concentration of serum required to assure specificity of 
reaction may vary somewhat from the figures given in Tables II and III. 
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From Table II it will be seen that a 1: 20 dilution of Type I serum, 
making, with the addition of an equal amount of pneumococcus sus­
pension, a final dilution of 1: 40,· a 1: 20 dilution of Type II serum, 
making a final dilution of 1: 40, and a 1: 5 dilution of Type Ill 
serum, making a final dilution of 1: 10, serve to agglutinate Types I, 
' II, and III pneumococci respectively and fail to show any cross 
agglutination reaction with strains belonging to Type IV. It will 
further be seen that with 0.5 cc. of undiluted Type II serum, as well 
as with the 1: 20 dilution, pneumococci belonging to the various sub­
groups of Type II may be identified- and rapidly differentiated from 
Type II pneumococcus, in that they sho-yv partial to complete agglu­
tination in undiluted Type II serum only, but not in the 1: 20 dilu­
tion at the end of 1 hour's incubation at 37°C. For the determina­
tion of types of pneumococcus in the peritoneal washings, these 
serum dilutions give the most satisfactory and clear-cut results. 
Five small test-tubes are set up as follows: 
Tube 1. 0. 5 cc. Serum I (1: 20) + 0. 5 cc. bacterial suspension.
" 2. 0. 5 " " II (undiluted) + 0. 5 " " " 
" 3. 0.5 " " II (1: 20) + 0.5 " " " 
" 4. 0.5 " " III (1: 5) + 0.5 " " " 
" 5. 0.1 "sterile ox_bile + 0.4 " " " 
Tube 5, containing bile plus bacterial suspension, is for the determi­
nation of the bile solubility of the strain and for the differentiation of 
pneumococcus from streptococcus. The tubes are incubated in .the 
water bath for 1 hour at 37°C. Agglutination of Pneumococcus Types
I, II, and III occurs promptly in these serum dilutions and is specific. 
Rapid clumping of the organisms is seen to take place and may be 
brought out clearly by gentle agitation of the tubes. For the iden­
tification· of atypical Type II pneumococcus, incubation is neces­
sary, these strains showing partial to atypical agglutination in un­
diluted Type II serum at the end of 1 hour's incubation. If no 
agglutination occurs in any of the serum tubes and the organism is 
bile-soluble, it is classified as Type IV pneumococcus. 
Precipitin Method.-The determination <?f. pneumococcus types by 
macroscopic agglutination tes�s with the peritoneal washings is inter­
. fered with when other organisms are present in considerable num­
bers, as occasionally happens, and consequently a delay of 18 hours 
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or more may occur before the type of pneumococcus present can be 
established. To obviate this, Blake (R9) has devised the following 
method: It has been shown that pneumococcus during the period of 
active growth in broth cultures produces a soluble substance which 
gives a specific precipitin reaction with homologous antipneumococcic 
serum. The method described by Blake is dependent upon this 
,phenomenon. The peritoneal exuda.te is washed out with 4 to 5 cc. 
of sterile salt solution in the manner already described under the 
agglutination method, and the peritoneal washings containing cells, 
fibrin, and bacteria are immediately centrifuged at high speed until the 
supernatant fluid is water-clear. The supernatant fluid is then 
pipetted off with care not to disturb the sediment, and is mixed in 
quantities of 0.5 cc. each with equal amounts of antipneumococcic 
serum in a series of small test-tubes as follows: 
Tube L 0.5 cc. Serum 
" 2. 0.5 " " 
" 3. 0.5 " 
" 4. 0.5 " 
"
"
I (1: 10) + 0.5 cc. supernatant peritoneal washings.
II (undiluted) + 0.5 " " " " 
II (1: 10) + 0.5 " " " " 
III (1: 5) + 0.5 " " " " 
An immediate specific precipitin reaction occurs in the tube contain­
ing homologous immune serum, the other tubes remaining clear (Table 
III). Incubation is usually not necessary. Two tubes of Type II 
serum are used for the purpose of distinguishing between Type II 
pneumococcus and members of its subgroups, the former giving a 
precipitin reaction in both tubes, the latter only in the undiluted 
Type II serum. A negative reaction in all serum tubes indicates 
pneumococcm; belonging to Type IV. The precipitin method has 
been tested with a large number of strains and has beeh consistently 
positive and speci:fi..c with Pneumococcus Types I, II, and III, and 
consistently negative with Type IV. The presence of other organ­
isms, together with pneumococcus, in the peritoneal exudate does 
not interfere with the reaction, and other microorgapisms than 
pneumococcus produce no substance,that might give a false positive 
reaction. 
The results with Subgroup II pneumococcus have not been so satis­
factory. Reference to Table III will show that pneumococci belong­
ing in these subgroups give a precipitin reaction with undiluted Type 
II serum, but not with the 1: 10 dilution, thereby being distinguished 
28 ACUTE LOBAR PNEUMONIA 
TA13LE III. 
Determination of Pneumococcus Types by the Precipitin Method. 
Serum I Serum II Serum II . Serum Ill Supernatant peritoneal (1: 10) (undiluted) (1: 10) (1: 5) washings 0.5 cc. 0.5 cc. o.s cc. 0.5 cc. 0.5 cc. 
Type I. ...................... ++ - - -". Il ........... : .......... - ++ ++ -
Subgroups Ila, b, x . .......... - + - -
Type III., .................. - - - ++ " IV ..................... - - - -
from typical Pneumococcus Type IL A number of Subgroup II 
organisms, however, have been encountered in which the peritoneal 
washings have_ failed to give a precipitin reaction with undiluted 
Type II serum. In the identification of the fixed parasitic types of 
pneumococcus, this occasional difficulty is of little practical impor­
tance from the point of view of treatment, as there is at present no 
specific therapy for cases of pneumonia due to organisms of ·these 
types. For purposes of classification and statistics, these organisms 
can be readily identified subsequently when pure cultures have been 
obtained. 
Confirmation of Types.-The determination of the type of pneu­
mococcus by examination of the peritoneal washings should be con­
firmed by macroscopic agglutination tests with a pure bouillon cul­
ture of pneumococcus obtained from the heart's blood at the time of 
mouse autopsy. The tec1mique is the same as that employed in the 
agglutination tests on the bacterial suspension obtained from the 
peritoneal washings. A test for bile solubility should also be made. 
Determination of Type III Pneumococcus by Morphologic and 
Cultural Characteristics. 
Of the four types of pneumococcus, the third type, Pneumococcus
mucosus, is the only one which can be identified in most instances by 
morphologic and cultural differences. Pn_eumococcus mucosus is 
usually somewhat larger, rounder, and less lanceolate than other 
types of pneumococcus. It possesses a large distinct capsule which 
stains readily with Hiss' capsule stain and which usually retains the 
pink counterstain with Gram's method. The peritoneal exudate 
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of a mouse infected with this organism is usually quite mucoid and 
.sticky, and the colonies on blood media are moist, mucoid, and con­
:fluent. Occasional strains, however, are encountered in which 
these characteristics are not so well marked and wh'.ich · are not so 
easily distinguishable by cultural or morphologic differences from 
other types. Furthermore, Pneumococcus Type II occasionally ex­
hibits fairly well defined mucoid characteristics. For these reasons 
the identification of Type III pneumococcus by morphologic and 
-cultural characteristics is not always absolute, and the diagnosis
�hould be established by immunologic methods, when Type III
·serum is available.
Determination of Types of Pneumococcus in Blood Cultures, Spinal 
Fluifl,S, Empyema Fluids, and by Lung Puncture. 
Blood Culture.-From a positive bouillon blood culture, 10 cc. are 
removed by pipette and centrifuged at lo'V-{ speed to remove the 
. blood cells. The supernatant fluid is pipetted off and the bacteria 
are thrown down by centrifuging at high speed. The supernatant 
fluid is discarded and the bacterial sedime?,t resuspended in sterile 
.salt solution. The type of pneumococcus is then determined by 
macroscopic agglutination tests following the technique described 
above. 
Spinal Fluids and Empyema Flitids.-Cultures are made by the 
methods ordinarily employed in culturing these fluids, and the type of 
pneumococcus is determined by the agglutination method, with the 
same technique as that applied _to blood cultures. If desired, in 
addition to culturing the fluids, a portion may be centrifuged at 
high speed to throw down the pneumococci present, and the bac­
terial residue may be taken up in 1 cc. of sterile salt solution and 
inoculated intraperitoneally into a mouse. 
Lung P,uncture.-This procedure should be resorted to only when it 
is impossible to obtain a suitc!.ble specimen of sputum or a positive 
blood culture. In our experience this procedure is necessary only on 
rare occasions. Cultures of the material obtained by puncture are 
made in bouillon, and the determination of type is made by the 
same technique as that employed in the case of blood cultures. 
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Determination of Types of Pneumococcus by Means of Specific Pre­
cipitin Reaction in the Urine. 
The fact has been mentioned that a certain percentage of patients 
suffering from lobar pneumonia excrete in their urine at some 
stage of the disease a soluble substance of pneumococcus origin. 
This substance gives a specific precipitin reaction with antipneumo­
coccic serum corresponding in type to the organism with which the 
individual is infected. A study of 111 cases of lobar pneumonia and 
closely related respiratory diseases has shown that in 65 per cent of the 
cases of pneumonia due to Pneumococcus Types I, II, and III, this 
substance is present in the urine and can be detected by means of the 
appropriate antipneumococcic serum. The reaction is spedfic for 
the type of ·pneumococcus with which the individual is infected,· 
and in no instance of respiratory disease due to organisms other than 
pneumococcus has a positive reaction been obtained. The soluble 
substance may appear ,in the urine at as early a period as 12 hours 
after the initial chill, or it may appear for the first time at a later 
stage of the disease. It may continue to be excreted for many days 
after recovery h� occurre_d. It is the rule to find this substance in the 
urine when pneumococcus septicemia exists. Examination of the. 
urine for the presence of this substance has proven of some value for 
the rapid determination of the type of pneumococcus with which the 
individual is infected. Methods for the performance of the precipitin 
test are therefore given in detail. This test, however, should not sup­
plant the usual bacteriologic metho�s for the differential diagnosis of 
pneumococcus types, but is useful in that in a certain percentage of 
instances an immediate diagnosis can be made from an examination 
of the urine. 
Method Using Unconcentrated Urine.-A specimen of urine is ob­
tained as soon as possible and cleared by centrifuging. The clear 
urine is mixed in quantities of 0.5 cc. each with equal amounts of 
antipneumococcic serum of the different types in a series ,of agglu­
tination tubes (Table IV). 
The strength of the reaction may vary from an almost impercep­
tible cloud to a heavy flocculent precipitate. The reaction may occur 
in some instances imID:ediately on the mixing of urine and serum, or 
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TABLE IV. 
Determination of Pneumococcus '.f'ypes by Precipitin Reaction in Urine. 
0.5 cc. urine from: 
Type I pneumonia ....... , .............. . 
H II " 
" III " 




Serum 11 Serum Ill 
0.5 cc. 0,5 CC, 
+ 
+ 
may require incubation in the water bath at 37°C. for 1 hour. Pro­
longed incubation, however, must be avoided, since bacterial growth 
under such conditions may obscure the test. In the precipitin reac­
tion it is essential that all the reagents used, including the immune 
sera, should be water-clear. In case the reaction is negative or so 
faint as to be indecisive with the whole urine, the following method 
of concentrating the urine may be employed: 
Concentration of Urine for Precipitin Test.-25 cc. or more of a 24 
hour specimen of urine, with the addition of a few drops of acetic acid, 
are boiled down to a volume of about � cc., filtered through paper to 
remove any precipitate of albumin that may occur, and the filtrate is 
added to 8 to 10 volumes of 95 per cent alcohol. The precipitate 
which forms is collected by centrifuging, rapidly dried to remove the 
excess of alcoh9l, and the residue extracted with 2 to 3 cc. of salt so­
lution, which redissolves the specific substance. Any undissolved 
material is removed by centrifuging and the clear salt solution ex­
tract is used for the precipitin test, as shown in Table IV. 
LABORATORY AIDS IN PROGNOSIS. 
Accurate prognosis in such an acute disease and one of such short 
duratio� as lobar pneumonia is very difficult. That the clinical pie-· 
ture may pass in the brief period of 24 hours from one that is ap­
parently favorable to one of extreme urgency is a common obser­
vation. In the early stages of the disease it is almost impossible from 
the clinical picture alone to predict the outcome, and even in cases · 
·ending fatally, it is frequently difficult, even during the last days, to 
say wh'1tt the result will be. 
In the course of the studies on lobar pneumonia at the Hospital of 
The Rockefeller Institute some facts have been determined which 
are of value in estimating the probable severity of any case of 
pneumonia, and in predicting the result. Studies of the bacteriology 
-0f a large series of cases of lobar pneumonia have shown that the 
type of pneumococcus with which the individual is infected plays a 
part of considerable importance in the probable outcome of the dis­
ease. In spite of certain reports to the contrary, our experience has 
led us to believe that the presence of pneumococcus in the blood 
during lobar pneumonia indicates a severe infection and is of bad prog­
nostic import. It has already been stated that during the course of 
lobar pneumonia there appears in the urine a soluble substance of 
pneumococcus origin. The quantity of this substance can be fol­
lowed from day to day, and the amount excreted seems to be 
directly proportional to the severity of the infection. In occasional 
cases the blood picture is of value in forecasting the outcome of 
the disease. 
Relation of Type of Pneumococcus to Mortality. 
A study of a large number of strains of pneumococcus and the out­
come of the disease in individuals infected with these strains has 
shown that the different types of pneumococcus vary in their viru­
lence for man. In Table V are shown the percentage incidence of the 
di:ff erent types of pneumococci in 100 cases of lobar pneumonia and 
the average mortality in those untreated with serum. 
32 
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TABLE V. 
Incidence of Various Types of Pneumococcus and Resulting Mortatity. 
Type of pneumococcus. Incidence. Mortality. 
per cent per cent 
I 33 25 
II 31 32 
III 12 45 
IV 24 16 
The statistics given in Table V approximate the facts as closely· 
as they can be ascertained at the present time. Organisms of Type 
. IV have in our experience been found to possess the lowest viru­
lence of the different types for human beings. Type III pneumococcus, 
although it is the cause of the smallest percentage of cases, never­
theless gives rise to a high mortality, and the outlook for a patient 
infected with Type _III prteumococcus is comparatively bad. Pneu­
mococci of Types I and II are responsible for about 64 per cent of all 
cases of lobar_ pneumonia and are of relatively high virulence for 
man, the largest number of deaths in lobar pneumonia being due to 
these organisms. The mortality in Type I infection is 25 per cent, 
and in infectfons with Type II pneumococcus about 32 per cent. 
These two types together are responsible for approximately 62 per 
cent of all deaths from lobar pneumonia. It is evident, therefore, 
that the outcome of any case of lobar pneumonia is influenced by the 
type of organism with which the individual is infected, and knowledge 
of the type of pneumococcus causing the infection is therefore of value 
in prognosis. It must be borne in mind, however, that there is con­
siderable variation in the severity of the individual cases due to the 
different types of pneumococcus. 
Specific Precipitin Reaction in the Urine. 
In the course of our studies it has' been found that pneumococci 
of Types I, II, and III during the active period of growth form a 
soluble substance. Type III pneumococcus forms the largest amount 
of this substance, Type II somewhat less, and Type I the least. The 
elaboration of this substance by Type IV pneumococcus has not been 
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studied because of lack of specific sera for this group. This soluble 
substance is formed not ·only on artificial growth in vitro but also 
during natural infection in man. In patients suffering from lobar 
pneumonia this specific substance can sometimes be demonstrated 
in the blood. It is, however, frequently present in the urine in 
easily demonstrable amounts. The quantity of this substance pres­
ent in the urine varies with the intensity of the infection and in-many 
instances furnishes a basis for estimating the severity of the disease. 
In Table VI are presented the relative frequency of occurrence of the 
specific precipitin reaction in the urine during lobar pneumonia and 
the outcome of the disease.in the cases studied. 
TABLE VI. 
Specific Precipitin Reaction in Urine in Lobar Pneumonia. 
lncldcnec. Mortality. 
Type 
Cases showing positive Cases showing negatin •f pneumo- No. of No. of reactions. reaction ... cocc1,1s. cases cases Positive. 
positive, negative. 
No. Died. No. Died. 
,,., ,e,u per ,mt per�,,., 
I 20 15 57.1 . 20 2 10.0 15 0 0 
II 20 8 71.4 20 10 50.0 8 0 0 
III 12 5 70.5 12 7 58.3 5 1 20 
The urine from 80 cases of pneumonia due to Pneumococcus Types
I, II, and III was studied. In 28 of these the urine showed no reac­
tion, and in 52, or 65 pe;r cent, the test was positive. The mortality 
among the positive Type I cases was low, probably due to the fact 
that all these cases were treated with specific antipneumococcic serum. 
Of the 32 cases of Types II and III infection giving a positive urine 
reaction, 17 died, a mortality of 53.1 per cent. Of 13 cases due to 
Pneumococcus Types II and III having a negative reaction in the 
urine, only one died, a mortality of 7.7 per cent. 
Most of the cases which fail to show the precipitable :,ubstance 
in the urine recover, whereas the mortality is high among cases in 
which its presence is demonstrable. The preseµ.ce of specifically 
precipitable substance in the urine during lobar pneumonia therefore 
seems to indicate a severe infection. If the amount present in the 
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urine increases from day to day, the outcome is usually· fatal unless 
this result is prevented by th� administration · of antipneumococcic 
serum. 
Significance of Pneumococcus Septicemia. 
The suggestion has been made that lobar pneumonia is primarily a 
b:k>od infection, and that the local process in the lung is but part of a 
generalized condition. This view has arisen from the discovety that 
pneumococcus may at times appear in the circulating blood of persons 
suffering from lobar pneumonia. Reports in recent years have varied 
considerably as to the frequency with which it is possible to ob'tain 
pneumococcus from the blood. Some observers have obtajned posi­
tive cultures in from 20 to 50 per cent of cases examined and, since 
these were the more severe cases, they think the.presence of pneumo­
coccus in the blood is of bad prognostic import. Others, _claiming 
more suitable technique, have found pneumococcus in the blood dur­
ing lobar pneumonia with great constancy and attach very little 
prognostic significance to its presence. In the cases of lobar pneu­
monia studied in the Hospital of The Rockefeller Institute, pneumo­
coccus has not been found in the blood in all instances: In those 
cases in which a positive culture was obtained, the· course of the 
infection has been invariably severe and in many instances the disease 
terminated fatally. 
In -Table VII are presented the results of blood cultures in a series 
of 448 cases of lobar pneumonia at the Hospital of The Rockefeller 
Institute. 
TABLE VII. 
Relation of Positive Blood Cultures to Mortality in Pneumonia. 
No. of 
Blood cultures. Mortality. 
Type cases of pneumo- exam- Cases with posi- Cases with nega,. coccus. lned. Positive. Negative. tive blood culture. tive blood culture. 
per uni per uni pu ,mt per ,wt 
I 145 so 34.S 95 65.S 13 26.0 3 3.1 
II 148 49 33.1 99 66.9 36 73.4 9 9.0 
Ill 55 16 29.0 39 71,.0 16 100.0 11 28.2 
IV 100 21 21.0 79 79.0 11 52.3 3 3.8 
Total. ..... 448 I 136 30.3 312 69.7 76 55.8 26 8.3 
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Examination of Table VII shows that of 448 cases of lobar pneu­
monia, pneumococcus was obtained from the blood in 136 instances, 
or 30.3 per cent. In spite of the apparently low percentage of positive 
cultures in comparison with the statistics of some investigators, we 
feel that this percentage is representative of the number of positive 
blood cultures obtained by the ordinary hospital routine of taking ·one 
or two blood cultures in each case of pneumonia. The taking of re­
pea_ted blood cultures during the course of the disease would probably 
raise this percentage. In 37 of these cases in which blood cultures 
were made at frequent intervals, positive :findings were obtained in 50
per cent. 
In the 136 cases with positive blood culture the mortality was 55.8 
per cent, whereas in 312 cases with negative blood culture the mor­
tality was but 8.3 per cent. These figures seem to show that the 
presence of pneumococcus in the blood during lobar pneumonia 
indicates a severe infection and is of bad prognostic significance. 
The type of pneumococcus obtained from the blood has an impor­
tant bearing on the outcome of the disease. · In 50 cases in which 
Type I pneumococcus was obtained from the blood, the mortality 
was 26 per cent. The fact that this figure is so low is undoubtedly 
dependent upon the fact that a large number .of these cases was 
treated with Antipneumococcic Serum Type I. Of 49 cases in which 
Type II pneumococcus was obtained from the blood, the mortality 
was 73.4 per cent. Of 16 cases in which Type III pneumococcus was 
recovered from the blood, the mortality was 100 per cent. Of 21 
cases in which Type IV pneumococcus was found in the blood, the 
mortality was 52.3 per cent. These figures indicate that, with the 
exception of infections with Type I pneumococcus, in which case 
specific serum is efficacious, the more virulent the type of pneumo­
coccus obtained from the blood, the less is the likelihood of recovery. 
Our experience has been that the greater the number of colonies of 
pneumococcus that �evelop from 1 cc. of blood when plat� cultures 
are made, the more likely the disease is to have a fatal termination. 
The following :figures indicate the significance of increas.ing numbers 
of pneumococci per cc. of blood. The illustration is drawn from 
our experience with plate cultures made from the blood of individuals 
with Type II pneumococcus infections. Of 14 cases in which the 
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numbers of colonies were from 1 to 15 per cc. of blood, 6 died, a mor­
tality of 43 per cent; of 2 cases with 15 to 30 colonies per cc., 2 died; 
of 4 cases with 30 to 75 colonies per cc., 4 died; of 16 cases with more 
than 75 per cc., 16 died. It is thus seen that all cases of Type II 
infection in which the number of colonies per cc. of blood was 15 or 
more were fatal. This figure, of course, is not to be considered as 
absolute, but �erves to show that cases of Type II infection with con­
siderable numbers of pneumococci per cc. of blood are almost 
invariably fatal. In some cases of lobar pneumonia, invasion of the 
blood may occur as late as the 5th or 6th day. A number of these 
cases are rapidly fatal and study of the blood has shown that the 
· · numbers of pneumococci per cc. of blood increased with extraor­
dinary rapidity, the number of colonies in many instances running
up into the thousands.
The study of these results leaves little doubt that invasi_on of
the blood by pneumococci in any type of lobar pneumonia is a
serious matter, that the seriousness of this invasion is propo!tional
to the virulence of the type of organism, and that the greater the
number of organisms present, the more likely is the disease to'have a
fatal outcome.
Technique of Blood Culture.-Under aseptic precautions 20 cc. of
blood .may be easily aspirated into a sterile Luer syringe from a
convenient vein, usually near the bend of the elbow of the patient.
The syringe may be sterilized by boiling for 20 minutes in a covered
receptacle, or sterilization may be accomplished by dry heat or the
autoclave, the syringe being enclosed in a large cotton-plugged test-.
tube. The latter method has the advantage of immediate avail­
ability when cultures are to be taken. The needles used are prefer­
ably nickeled steel needles of about No. 18 gauge_ The bevelled.
points should be sharpened each time before using, to insure ease in
penetrating the vein and to reduce the discomfort of the patient-to a
minimum. With nervous individ'qa}s or in those cases where small
veins or adipose tissue give promise of difficulty, the skin may be m·­
filtrated with a little 1 per cent novocaine solution. Then, if any
trouble is experienced in piercing the vein, the proc�dure will at.
least be painless.
When the blood is obtained 10 cc. are added to a flask of 150 cc. of 
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plain beef infusion broth (page 19) previously wanned 'to body tem­
perature, and immediately incubated. The remainder of the blood is 
added in varying amounts to melted plain agar cooled down to about 
45°C., a.nd plates are made. Usually after 18 to 24 hours' incubation 
at 37°C ., if the broth culture is positive, the supernatant fluid be­
comes diffusely turbid, and, on shaking, the mixture appears brownish 
red to chocolate in color. If very few organisms are present, several 
days may elapse before any change in the color of the cultures takes 
place. Consequently broth cultures should be incubated for 7 days 
a.nd subcultures made on blood agar slants before they are considered 
sterile. 
Colonies on the agar plates usually appear as small white dots, 
surrounded frequently by a greenish black area due to methemoglobin 
formation. Identification of the organisms obtained from the broth 
a.nd agar cultures should be made by the methods described pre-
viously (page 29). 
Leukocytosis. 
It is well known that lobar pneumonia is usually accompanied by an 
increase in the total number of leukocytes in the blood, as well as 
by a relative and total increase in the percentage of polymorpho­
nuclear cells. When such a leukocytosis is absent, it may �ean a 
relatively mild infection or an overwhelming one. · Chatard (1), in an 
analysis of 582 cases of pneumonia at the Johns Hopkins Hospital, 
found a mortality of 55 to 60.per cent in 39 cases having a leukocyte 
count under 10,000. With the rise in the number of leukocytes from 
10,000 to 30,000 there was a progressive decrease in the mortality. 
Similar experience has been derive.cl from obseryations of the leuko­
cytes in 463 cases of lobar pneumonia in adults studied at the Hospital 
· of The Rockefeller Institute. Table VIII shows the same striking
·increased mortality where the leukocytes were below 10,000 per cc.,
as found by Chatard, and a ·similar progressive fall in mortality with
increasing leukocytosis.
While a single observation of white blood cells may furnish infor­
mation of prognostic value, a study of the variation in the num­
ber and character of the leukocytes during the course of the dis­
ease has revealed many points of interest. It has been· noted that
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TABLE VIII. 
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The Relation of Leukocytes to Mortality in Lobar Pneumonia. 
Leukocytes. 
Under 10,000 ......................................... . 
10,000-20,000 ........................................ . 
20,000-30,000 ........................................ . 
30,000-40,000 ........................................ . 
40,000-50,000 ........................................ . 
Above 50,000 ......................................... . 
Total. ............................................. . 
















when conso�idation of the lobe or lobes is taking place or during the 
period when a spread or infection of a new area of the lung is in 
progress, there may be a well marked decrease in the number of 
leukocytes. The following observations made on a patient having a 
Type I pneumococcus infection are illustrative: 
Day of disease. Leukocyte Polymorpbo- Lymphocytes. Large mono- Temperat�re. count. n11clears. nuclears. 
per ,enl per ,en/ per tent •p, 
2 15,600 97 3 105 ' 
3 13,700 89 8 3 103.6 
4 11,200 94 4 2 103.4 
5 8,100 -88 7 5 103.6 
Lesion spreading from lower to upper lobe. 
6 9,200 78 5 17 103 
7 14,600 89 5 6 103.8 
8 12,600 88 5 7 103.4 
10 16,400 78 6 16 103 
11 13,200 85 10 5 100 
12 17,200 72 15 13 99.8 
13 9,200 79 3 17 100.4 
14 8,800 79 11 10 100.5 
In this case a single observation made on the 5th and 6th days of
the disease during the spread of the lesion from the lower to the
upper lobe might have given one a false impression of the severity
of the process. 
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A steady rise in the leukocyte count during the course of the 
disease is usually of favorable import. The following case illustrates 
this point: 
Da.yof Leukocyte Polymor- Lympbo· Large mono- Transi- Eoslnopbils. Temper-
disease. ' count. phonuclears. cytes. nuclears. tionals. a.ture. 
pu,enl per ,e,11 pu,ml pu cenl ,per ce11I •p,
4 9,400 93 4 3 103.6 
5 9,400 96 4 
13,600 87 4 7 2 103.6 
6 14,400 88 s s 2 103.2 
14,500 86 13 1 103.6 
7 18,700 94 6 101.4 
20,000 86 4 5 s 100.2 
8 14,400 84 6 5 4 1 99.2 
12,000 85 3 6 2 4 100 
10 9,000 78 6 13 3 98.8 
12 8,800 68 10 16 4 2 99.2 
On the other hand, if an initial low leukocyte count ·shows little 
or no tendency to rise even with specific treatment, the prognosis 
may be grave. This is illustrated by tlie following case: 
Day of disease. Leukocyte count. Tempenitu.re. 
•p. 
3 8,000 102.5 
4 7,200 102.8 
8,800 102.8 
5 11,900 102.5 
6 12,300 102 
7 Died. 
With the fall in temperature by crisis or lysis, the number of leuko­
cytes in the blood rapidly falls in the uncomplicated cases. A con­
tinuance of the high count, especially if accompanied by a continued 
high percentage of polymorphonuclear cells, suggests a complication 
with pus formation, most frequently empyema or otitis media. A 
continued leukocytosis with diminishing polymorphonuclear cells and 
corresponding rise in lymphocytic cells, with the presence of a few 
eosinophils, suggests delayed resolution, or serum sickness if the case 
has been treated with specific serum. 
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, The appearance and staining qualities of the white blood _ cells 
often reflect the condition of the patient. In those mortally infected, 
in addition to an abnormally small number of leukocytes, there may 
be a predominance of degenerated polymorphonuclear cells. The 
nuclei of these cells appear fragmented, stain poorly, and the cyto­
plasm presents an appearance suggesting cloudy swelling. 
On the other hand, a day or two before crisis, together with the 
increase in the total number of cells, there may appear many poly­
morphonuclear cells which may be termed immature forms. The 
nucleus is large and succulent in appearance and contains large 
amounts of chromatin material. The cytoplasm of the cell is, in 
addition, packed with well staining coarse granules. These minor 
changes that take place in the white blood cells in the presence of an 
infection, while of less practical value from the standpoint of prog­
nosis than the information that may be derived from the deter­
mination of the type of infecting organism, the presence or absence of 
precipitable substance in the urine, or the occurrence of pneumococcus 
in the blood, are nevertheless of considerable importance. 
ANTIPNEUMOCOCCIC SERUM. 
It was demonstrated as early as 1891 that animals such as the rabbit 
can be rendered immune to lethal doses of pneumococci by the pre­
vious injection of sublethal doses of the organisms or by the injec­
tion of dead cultures. Furthermore, it was shown that the serum of 
these immune animals is able to pr0tect .other animals against a fatal 
infection, and even to cure them. after infection has once occurred, 
provided that the injection of the serum is not too long delayed. It 
is not surprising that attempts were at once made to apply these 
fundamental facts to -the, treatment of lobar pneumonia in man. 
The serum of horses immunized to pneumococci has been widely 
employed in treatment (17, 20, 25,26, 32, 33), but the results obtained 
have been inconclusive, and a few years a.go the concensus of the 
best clinical opinion was that antipneumococcic serum was of little 
or no value. 
It must be remembered that most of these efforts to treat pneumonia 
with immune serum were made before we had any knowledge concern­
ing the immunologic differences between various ra;ces of pneumococci; 
they were all considered identical. Moreover, at the time these at­
tempts were made to employ immune serum, there were no methods 
for accurate etiologic diagnosis in the individual cases, and the 
serum was administered to all cases indiscriminately. It is little 
wonder, therefore, that the results of treatment were unsatisfactory 
and inconclusive. Moreover, the immune sera were employed in 
small amounts and were injected subcutaneously. 
We now know from experiments on animals that an antipneumo­
coccic serum is only protective and curative provided it is employed 
to combat an infection due to the same type of organism as that 
used in its production. We also know that to cure after 'infection 
has once occurred, the serum must be employed in very large amounts, 
and preferably injected intravenously. 
The discovery of these facts, together with the development of 
methods for making an etiologic diagnosis in every case, made it 
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advisable to undertake again the treatment of cases of pneumonia. 
with the serum of horses immunized to the various specific types. 
These attempts have resulted in the demonstration that antipneumo­
coccic serum, prepared by the injection of Type I pneumococcus, is 
highly effective in the treatment of cases of pneumonia due to the 
same type of organism. The serum of Type II is much less effica­
cious. Indeed, it has not yet been thoroughly demonstrared whether 
it has any practical effect on the outcome of the disease or not. 
Immune serum may be prepared by the injection of Type III pneumo­
cocci and this serum has slight agglutinating power and slight protec­
tive power for animals (30). This power, however, is so slight that the 
therapeutic application of this serum has not been considered prom­
ising or justifiable. From what has previously been stated it would 
be impossible to prepare a serum which would be effective against 
any considerable number of cases of infection due to Type IV 
pneumococc1. 
Production of Serum. 
In spite of all that has been written concerning the theoretic prin­
ciples involved in the preparation of antipneumococcic serum, and in 
spite of all the reports of the therapeutic application of various sera 
which have appeared, very little has been written concerning the 
actual method of preparation of these sera. In general, they have 
been prepared by the injection into horses at weekly intervals of 
gradually increasing doses, first of dead, then of living pneumococci. 
Based on certain experimental studies which 'have been carried on 
in the Hospital of The Rockefeller Institute, this method of producing 
the ser'l;lm has been modified, so that the time required has been 
materially lessened (R31). 
What is attempted in the production of 'immune serum is to obtain, 
as rapidly as possible, a serum possessing the highe'st possible content 
of the known antibodies, agglutinins and bacteriotropic substances, 
and the highest possible protective action against pneumococcal jn­
fection, as tested in mice. Whether such a serum meets all the theo­
retic requirements is not at present our concern. Moreover, this 
serum sh�uld be specific; that is, effective against the type of pneumo­
coccus causing the infection. Up to the present time antipneumo-
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coccic serum has been demonstrated to be effective only in cases 
due to Type I pneumococcus, so in our opinion the production of anti­
pneumococcic serum for routine practical use should, for the present, 
be confined to that prepared by the injection of this type of pneumo­
coccus. At the present time the production of a polyva1ent anti­
pneumococcic serum is not practical or important, as it is in the 
case of the production of polyvalent meningococcic serum, for in­
stance. The conditions as regards specificity among meningococci 
are quite different from those obtaining among pneumococci. The 
former organisms also differ among themselves in their immunity 
reactions. However, they all possess certain common characters, 
so that an immune serum against any one type has some action 
against all meningococci. With pneumococci, at least as regards the 
first three types, the immunity reactions are almost absolutely 
specific. A Type I serum is hardly more effective against infection 
due to Type II pneumococci than antidiphtheria serum would be. 
For these reasons we do not advise the routine manufacture of 
polyvalent antipneumococcic serum. 
Concerning the size and spacing of doses, we have found from numer­
ous experiments in rabbits that instead of the old method of weekly 
injections, much better results are obtained if the injections of dead 
organisms are made daily for a period of 7 days; then after another 
period of 7 days elapses, a similar series of injections is made. It has 
been proved that the doses should be small, as very large doses inhibit 
the immunity response. After several series of injections of dead cul­
ture, it may be necessary to employ the live bacteria. Here it is 
well to take advantage of the observations of Fornet and Muller, 
which have already been used by Flexner and his assistants in the 
manufacture of antimeningitic and antidysenteric serum. In this 
method the injections are made daily over a period of 3 days, deter­
mining the size of the dose largely by the reaction obtained. The 
following is a brief statement of the method of immunizs1,tion as 
actually employed by us at present: 
Technique of Immunizing Animals.-A sound, fairly heavy horse 
should be chosen and quarantined until a glanders test is performed. 
A specimen of blood obtained before any treatment is given is kept 
as a control. The immunization is carried on as follows: All in-
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jections are made intravenously, employing for this purpose a Luer 
syringe. To avoid any accidental injury to the vein it is weil 
to have the needle attached to. the syringe with a small piece of 
rubber tubing. The strain of pne'll:mococcus (living or dead) which 
is used for injection should be one highly virulent for mice (0.000001 
cc. kills regularly) and it should have had very few passages either
through animals or in artificial medium since removal from the
human patient. The method for keeping these cultures is described
above (page 13). In preparing the material for injection, both liv­
ing and dead organisms, cultures are grown on beef peptone broth,
reaction 0.3 to 0.5 per cent acid to phenolphthalein. Cultures about
12 to 15 hours old are preferable, as at this time maximum growth is
present, with a minimum of autolysis. The cultures should contain
about 200 to 300 million bacteria per cc. The culture is centrifuged
until the supernatant fluid is clear. With the large centrifuge em­
ployed by us this req�ires about 20 minutes to an hour. The super­
natant fluid is then pipetted off and the sediment is taken up in a small
amount of sterile salt solution.
If living organism�- are to be injected, the emulsion in salt solu­
tion is not made until just before injection, so that death and auto­
lysis may not occur. If the organisms are to be injected dead, the 
emulsion is heated in a water bath at 56°C. for half an hour. For the 
daily injections a considerable amount of the vaccine is prepared as 
above and kept on ice. This vaccine may be employed for all the 
injections in one series of 6 to 7 days. We think, however, that a 
fresh emulsion should be prepared for each new series. Of course the 
emulsion of live bacteria should be freshly prepared for each injec­
tion. The dilution of the injected fluid should be such that the 
total volume is about 20 cc. 
The following course of injections is now carried out: Every day for 
6 days an injection of the emulsion containing bacteria from 50 cc. of 
bouillon. culture is made. An interval of 7 days is allowed to elapse 
and then a second series of daily injections of the same sized doses 
is made. Again an interval is allowed to elapse and on the 6th 
day a specimen of blood is obtained foT testing. Tests are made at 
once for agglutinating and protective power. This requires several 
days. 
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If the serum causes agglutination in a dilution of 1: 200 and is of 
standard protective value, that is, 0.2 cc. protects a mouse against 0.1 
c�. of virulent culture, bleeding could be carried out at once (10th 
to 12th day). As a matter of fact, we have never seen the titer of the 
serum after this amount of treatment to be so high. Consequently 
it has been our practice, 8 to 10 days after the last injection of the 
second series of dead cultures, to commence injections of living bacteria. 
Three injections are given on successive days. The temperature of 
the horse is taken every 2 hours for 8 to 10 hours following each of 
the injections of living bacteria. The first injection should contain the 
bacteria from 2.5 c·c. of the original culture. If the temperature re­
action following this injection is only moderate; not over 40.5°C., a 
second injection of the bacteria from 5 cc. growth is given on the fol­
lowing day. If the reaction from this is only moderate, the dose is 
again doubled on the following day, the bacteria from 10 cc. of bouillon 
being injected. It must be stated that as far a� pneumococci are con­
cerned it is difficult to regulate the dosage entirely by the febrile re­
action obtained. If the reaction is very severe, of course the dose is 
made smaller than that mentioned. On the other hand, even though 
the reaction is very slight, we do not advise giving more than the 
amounts stated. 6 days after the last injection another specimen of 
blood is obtained for testing. If the serum is of the standard strength, 
bleeding can now be done. If, however, the potency is still too low, a 
second series of injections of living bacteria is made. These injections, 
unless there are reasons for modifying them, should consist of the bac­
teria from ·20, 40, and 80 cc. of broth on the 3 days respectively. 
Again, the size of the doses may need to be somewhat modified, on 
account of the severity, or the lack, of febrile reaction. Most horses 
will require still further injections of living cultures. In any case, we 
think they should be made in series of three, given on successive days, 
with 7 day intervals between the series. The third series in most 
horses may consist of the bacteria from 100, 150 and 200 cc .. of broth. 
From ou� present standpoint we believe that the size of an injection 
should never exceed the bacteria from 300 to 400 cc. of broth. Fol­
lowing the bleeding, it is well to allow the horse to remain quiet for 
3 or 4 days. Then a series of three injections of living cultures, 
50, 80, and 100 cc., is again given. After a week the serum is again 
I' 
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tested, and if of standard strength, bleeding may be done on the 10th 
day. If the serum is not sufficiently s·trong, a second series of in­
jections of living bacteria is given, 'again keeping the dosage fairly 
small, never giving more than the bacteria from 300 to 400 cc., and 
always bleeding about 10 days after tli.e last injection. 
Technique of Obtaining Serum.-The bleeding of the horse usually takes place 
about 10 days after the last injection of antigen. It is possibly well to allow the 








TEXT-FIG. 1. Bleeding jars. 
and its coat washed down with a dilute lysol solution. The floor, walls, and 
ceiling of the bleeding room are also washed down. The neck of the horse over 
the external jugular vein is shaved, washed with alcohol, painted with tincture 
of iodine, and anesthetized with a sterile 2 per cent solution of novocaine. The 
skin over the vein is incised and the vein is punctured with a cannula bearing a 
rubber tube, through which the blood is drawn into the receiving Jar. This 
cannula is 8 cm. in length and 5 mm. in bore; the end of the cannula is bevelled 
for 1.5 cm,, has a sharp point, and the bevel is turned against the blood stream. 
The bleeding jar (Text-fig. 1) is of glass, cylindric in shape, open at the top, 28 
cm. in height, and 16 cm. in diameter, a slight modification of the type of jar
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,described by Kraus and Levaditi (8); we have found "Nonex" glass very satis­
factory. The jar bears a loosely fitting cover of tinned copper having an ec­
,centric and a concentric opening; the former carries an ordinary cork through 
which passes the glass,inflow tube (A), to which is connected the rubber tube from 
the cannula; the inflow tube reaches about 1 inch below the cover. Suspended 
1from the cover, when it is in position on the jar, is a flat octangular weight (B) 
,of tinned copper, with an aperture through which the inflow tube passes. This 
weight is 14.5 cm. in diameter and weighs about 700 gm. On the under surface 
<>f the weight are four projecting points or teeth, about ½ inch in length, which 
serve to prevent it from slipping off the clot when dropped. The weight is sus­
pended in the jar by a loop of wire (C) which passes through the concentric open­
ing in the cover. By means of a small piece of wood or metal (D) passed through 
· this loop, the weight is held in position. This piece of wood acts as a trigger
which, when withdrawn, allows the weight to fall on the clot.
When the cover, weight, and inflow tube are in position on the jar, the whole
is covered by a layer of paper which is tied around the jar. Through the paper
the inflow tube is allowed to pr9,ject. On top 9f this, the inflow tube still pro­
jecting, is placed a layer of cotton and another layer of paper, and these are tied
securely; a cotton cap enclosed in paper is now secured over the inflow tube.
A cord (E) attached to one end of the wooden support of the weight comes to
the exterior through the paper and cotton covers. The jar so prepared is steril­
ized in the autoclave at 15 pounds' pressure for 20 minutes and afterwards dried
at 100°C. by dry heat. It is advisable to place a few cc. of water in the jar before
placing the latter in the autoclave.
Each jar is graduated and usually 3.5 liters of blood are drawn into each one.
The cannula and tube are sterilized by boiling for 20 minutes. The cannula
should have a sharp, cutting edge, which should be protected during sterilization
by wrapping the instrument in cotton. When the cannula is withdrawn from the
vein, usually no difficulty is experienced in stopping the blood flow, pressure and
perhaps a stitch in the skin being sufficient in most cases.
6 to 8 hours after the bleeding, when the dot is firm, the trigger supporting
the weight is released by pulling the attached cord (E); the weight then drops on
the clot and materially aids in expressing the serum. The serum is usually
drawn off the clot by syphonage about 40 hours after the bleeding, the short limb
of the syphon being introduced into the jar through the central opening (now free)
in the cover. The serum is syphoned into flasks of 6 liters' capacity. The long
limb of the syphon passes into the flask through a doubly perforated rubber cork.
Through the other perforation there passes a short cotton-plugged glass tube
through which partial exhaustion of the flask starts the syphon action. {::are
should be taken in the syphonage not to carry over particles of clot or cellular
debris. The serum is stored in these 6 liter flasks, sealed with rubber corks, and
capped with sterile tin-foil. The syphon and corks are sterilized by boiling and
the bottles (plugged with cotton and capped with paper) are sterilized in the
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autoclave and afterwards dried at 100°C. by dry heat. Usually at a single 
bleeding 9 to 12 liters of blood are withdrawn and from this, employing the method 
described, we have usually obtained a yield of SO to 55 per cent of serum. 
Storage of Serum.-Tbe serum is stored in the refrigerator in the 6 
liter bottles for at least 2 months. During this period· a fine pre­
cipitate gradually sediments. It is desirable that this sedimentation 
should be complete before the serum is dispensed for treatment in 
order to avoid the possibility of certain reactions on the part of the 
patient, due to the intravenous injection of suspended particles. 
Dispensi-ng Serum.-After the requisite period of storage, the serum 
is dispensed for treatment in sterile, rubber-corked bottles of 100 cc. 
capacity, capped with parchment which has been soaked in 1: 20 
phenol. This final bottling of the serum is accomplished by syphon­
age; this time, however, the syphon action is started by raising the 
air pressure in the storage flask through a co(ton-plugged tube in the 
rubber stopper through which the syphon tube also passes. The 
syphon tube terminates in a specially designed filling device which, 
by means of a protecting bell or jacket, covers the neck of the dis­
pensing bottle, thus avoiding unnecessary exposure of the serum. 
All the handling of the serum is conducted in a room free from 
draughts and dust. After bottling, the serum is tested for aggluti­
nation and protective power and it is also subjected to a rigid test for 
sterility and for primary toxicity. 
Tests for Sterility. Culture Tests.-The first, middle, and last of 
the dispensing bottles from each storage flask of serum are set aside 
for sterility tests. From each of these bottles,0.5 cc. and 4 cc. of serum 
are each mixed with about 20 cc. of 1 per cent glucos_e broth in Smith 
fermentation tubes layered with paraffin; 2 fC· of serum are mixed 
with about 15 cc. of melted 1 per cent glucose agar at 43°C. in deep 
tubes, and, after cooling, layered with paraffin; 6 cc. of the serum are 
mixed with 150 cc. of ordinary nutrient broth; all are then incubated 
at 37.5°C., and observed for 14 days. If no growth or gas produc­
tion is observed in any of the cultures, the particular lot of serum is 
considered sterile. 
Animal Tests.-4 cc. of the serum are injected subcutaneously into 
each of two guinea pigs weighing 250 to 300 gm.; the guinea pigs are 
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observed for 2 weeks for evidence of toxicity or infection. 0.5 cc. of 
serum is also injected into each of two mice which are observed for 4 
days. This test is for the purpose of making sure that the serum 
contains no living pneumococci from the last injection. However, in 
these tests we have never found pneumococci present. 
Use of A
rt
tiseptics.-Employing the precautions we have mentioned, 
it has been rare for any lot or sample of serum to become contami­
nated. Where large amounts of serum are injected intravenously, as is 
necessary in this form of treatment, the ideal method is to employ 
serum to _ which no preservative has been added, and under the 
conditions in which we have employed the serum, we have shown that 
this is practical. The serum should, of course, be kept in the dark 
I and in the cold. Under these conditions serum which we have kept 
several years has remained uncontaminated. If manufacturers 
feel that this method on a large scale is impractical, chloroform or 
tricresol may be added to the serum before bottling. 
At present, most State Board of Health laboratories employ chloro­
form for the preservation of serum which is to be injected intrave­
nously, and this is probably preferable to tricresol or other phenol 
preparations, though in the treatment of cholera large doses of immune 
serum, which have contained 0.5 per cent phenol, are said to have been 
employed (7) without injurious effects. Undoubtedly, however, 
where large amounts of serum are to be injected, the use of a volatile 
preservative, as chloroform, is preferable. The following is the 
method at present employed by the Department of Health of the City 
of New York: After the serum is drawn into the large flasks, an 
excess of chloroform is added, about 5 cc. to 1 liter. When the serum 
is drawn off for bottling, the excess of chloroform is left, together 
with the sediment, at the bottom of the flask. 
Preservation of Potency.-We have examined samples of serum kept 
on ice and in the dark after a period of 2 years. No loss of strength 
could be detected by the methods used. If allowed to stand at room 
temperature and in the light, a fairly rapid, loss of potency occurs. 
In the experience of Neufeld and Handel (14) also, antipneumo­
coccic serum keeps many months unchanged. They also found that 
neither heating to 59°C. nor the addition of carbolic acid causes any 
loss in potency. 
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Concentration of Serum.-Experimental evidence and clinical ex­
perience have demonstrated that antipneumococcic serum must be 
administered in large doses if success is to be obtained in this method 
of therapy. Any method of concentrating the serum without de­
creasing its antibacterial potency, therefore, would be of great value 
in rendering its administration more convenieq.t and practical. If 
concentrated serum were employed, moreover, the frequency of 
serum disease would be decreased, or at least the symptoms would be 
ameliorated. 
Study of the distribution of the immune bodies occurring in anti­
pneumococcic serum has shown that both the agglutinins and protec­
tive antibodies are associated or combined with the globulins, and 
not with �e albumin of the serum (R2). Hence concentration 
by fractional precipitation of the globulin fraction with ammonium 
sulfate is possible. This procedure; however, is attended with cer­
tain disadvantages. Bacterial contamination of the serum neces­
sarily occurs during the procedures attending the chemical manipu­
lations. Although the bacteria may be removed by filtration through 
a Berkefeld filter and their growth inhibited by the addition of pre­
servatives, the products of bact"erial metabolism remain and may ex­
hibit a toxic action when injected intravenously. It is doubtful, 
therefore, whether serum · concentrated in this manner should be 
employed for intravenous use. 
Gay and Chickering (R15, R16) have shown that the mixture of a 
solution of pneumococcus bodies and homologous antiserum results 
in the formation of a voluminous precipitate, which contains practi­
cally all the immune substances of the serum. The immune 
bodies contained in this precipitate can now be extracted in a dilute 
alkaline solution at 42°C. The resulting water-clear extract possesses 
the power to protect animals against pneumococcus infection and it 
also contains other demonstrable antibodies, such as agglutinins 
and precipitins. By this meth?d a large proportion of the antibodies 
can be concentrated in a volume which is only one-fifth to one­
tenth that of the original serum, and in which there is only one-sixtieth 
of the native protein. This biologic method of concentrating anti­
pneumococcic serum, while yielding an end-product which is ideal 
in many ways, is nevertheless laborious in technique, and the prep­
arations obtained are of very inconstant strength and are not stable. 
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While, ther.efore, concentration of antipneumococcic serum can be 
effected by either chemical or biologic methods, the disadvantages 
attending both of these processes are such that as yet neither has 
been found of practical utility. 
Standardization of Serum. 
In order that any serum may be used therapeutically, it is important 
that there should be some method of determining the strength or po­
tency of the samples employed. Without this, no constant dosage 
can be obtained, and any estimate of the effectiveness of the serum 
is difficult or impossible. The method used for standardization of 
antitoxic sera, such as diphtheria and tetanus antitoxin, is almost 
ideal. Here it is possible to establish toxic and antitoxic units, 
and the law of multiple proportions holds good for these units within 
very wide limits; if 1 cc. of serum neutralizes 1,000 units of toxin, 
0.001 cc. will neutralize 1 unit of toxin, or 100 cc .. will neutralize 100,000 
units, almost with the constancy of chemical acid-base neutralization. 
An analogous method of standardization for antipneumococcic 
serum has been proposed, but there are great difficulties in the 
way of using such a method for this serum. No pneumococcus toxin 
has yet been demonstrated and the employment of an antitoxic unit 
is therefore impossible. Nevertheless, it might be possible to make 
use of the same principle of standardization, using bacteria themselves 
instead of their toxin, provided that a minimal lethal dose of bac­
teria could be est�blished, and provided that the reaction between 
the minimal lethal doses and varying quantities of serum obeyed the 
law of multiple proportions. The attempt to employ such a method 
has been made by Eyre and Washbourn (3) and others. The establish­
ment -of _a minimal lethal dose of pneumococci, however, is a matter 
of extreme difficulty. Pneumococci vary greatly in their virulence 
from time to time. With every passage through an animal or on 
artificial culture medium, an alteration occurs. This change may 
not appear very great, as estimated by our usual methods, but 
in relation to the great accuracy required in the establishment of 
a minimal lethal dose, the changes are enormous. It is only in organ­
isms possessing the maximum degree of virulence that the virulence is 
at all stable. However, when cultures of high virulence are inoculated 
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into susceptible animals, as rabbits or mice, which are usually employed 
for these tests, it is found that v.ery few bacteria, at times even a single 
organism, are sufficient to cause a fatal infection. With these bacteria 
the determination of the minimal lethal dose would be extre�ely 
difficult, if not impossible. Our studies indicate, however, that if 
such a unit could be established, the antiserum, when tested against 
it, would probably be found to obey the law of multiple proportions. 
Nevertheless, on account of the difficulty of accurately establishing a 
minimal lethal dose, this method does not at the present time seem 
practicable. 
This failure to establish a unit for antipneurnococcic serum, how­
ever, is not so serious as it might seem. The main practical object 
to be gained by the employment of thls method of standardization 
would be that the dosage might be very accurately regulated, and that 
sera of weak power might be employed, provided that a sufficient 
amount were used. However, experience has shown that the maxi­
mum strength of any antipneumococcic serum that can be produced. 
by present methods is limited. This limit is quite constant and 
differs for the different types of pneumococci employed. In order to 
obtain practical results in treatment, even with serum of this maxi­
mum strength, very large amounts must be used. Therefore, even 
if we had such a method of standardization as that above mentioned',. 
it would not be practical to employ sera of low potency, nor would 
it be of great ad.vantage to be able to estimate very accurately the· 
exact potency of the dosage. Such a method of standardization of 
antipneumococcic serum therefore i�, at the present time, neither­
possible nor necessary. 
In the abse�ce of an absolute standard, it might be possible to­
devise a test for determining the relative value of different sera, 
by making use of certain phenomena, as agglutination or opsoni­
:fication. In these phenomena, if the amount of bacteria employed 
is not too great, the reaction is entirely proportional to the con�­
centration of the serum in the mixture, not to its actual amount. 
At ]east, the only method we have at present for measuring the 
power of a. serum to produce agglutination, consists in the determi­
nation of the maximum dilution at which the serum acts, and this is. 
practically independent of the number of bacteria acted upon. There.:..
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fore, if the effectiveness of a given serum depended upon its agglu­
tinating power or were proportional to it, this property could be em­
ployed to fix the strength of any serum, and in such a, method the· 
great variable, the living bacteria, would be eliminated. Even in
the absence of an absolute standard, we should then have a relative 
standard of efficiency. If bacteriotropic power were employed, how­
ever, the bacterial varlable would not be eliminated, since it has 
been shown that different bacteria vary greatly in the�r susceptibility 
to the action of bacteriotropic sera, and this variation is to some 
degree dependent upon virulence. In any case, however, the hope of 
,devising a method of standardization, employing either' agglutination 
or bacteriotropic action, has been destroyed by the observation that, 
while there is frequently some gross quantitative relationship be­
tween the protective action of a serum and its agglutinating or bac­
teriotropic power, this relationship is inconstant. For instance, we 
have had sera with high protective power and little or no agglutinating 
power, and vice versa.
Although it is not p�ssible to establish an anti-infection unit and 
although it is not possible to employ the properties of agglutination or 
opsonifica.tion in the ways we have mentioned for estimating the rela­
tive strength of sera, it is still possible _to have a sta:ndard that will 
be of great practical value in the therapeutic employment of this 
serum. If a minimum potency for those sera that are to b� employed 
therapeutically can be established, which minimum is not far be�ow 
the maximum possible, we shall have gone far in standardizing the 
treatment of cases by serum, even though this method does not 
make possible :fine distinctions in dosage or the use of sera of weak 
strength. It is, of course, necessary that serum of �e strength de­
termined upon can be produced without too great difficulty. Other­
wise great waste would result and the whole method would be­
.come impractical. . In view of what we have already stated in regard 
to agglutination and opsonification, these properties cannot be em­
ployed, but the potency of a given serum must be ascertained'by direct 
,determination of the protective power of the serum for animals. In 
·-Order to establish by this method such a limit of potency .as we have
�suggested above, thete must be some constant relationship between
-the size of the infection dose and t.he amount of serum nec�ssary to
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protect; in other words, the serum must obey the law of multiple 
proportions. 
' 
Neufeld (14), who first studied this qtiestion, decided that antipneumococcic 
serum, as tested by protective power, obeyed this law only within given limits 
and under certain conditions. His experiments seemed to show that the results 
were regular until the serum had been diminished to a certain amount, depending 
on the weight of the animal employed. When an amount of serum less than this 
· was employed, the relation of serum to culture no longer held constant; this
smaller amount of serum would protect only against a very much less amount of
culture t�an that calculated. From this he judged that to obtain effective action,
even against minimal doses of culture, a give}l concentration of serum in the body
(not actual amount) is required. This effective limit to the action of serum he
called the S chwellenwert. His experiments were performed on mice and he did
not mix the culture and serum before injection, but injected them separately
in different parts of the body and usually allowed a period of time to elapse be­
tween the injection of the serum and that of the culture.
This matter was later studied in this hospital, but rats were· em­
ployed and the given amount� of culture and serum were mixed in 
the syringe immediately before injection. It was found that the law 
of multiple proportions held valid as long as small amounts of 
culture and serum were employed; that even extraordinarily small 
amounts of serum would protect against proportionally small doses 
of culture. The relative amount of serum necessary to protect against 
larger doses of culture became greater and greater, however, as the 
size of the doses of culture was increased, until :finally no amount of 
serum, however large, was able to protect. 
The explanation of Neufeld's results lies in the fact that the serum 
was injected separately from the culture and, owing to the length of 
time required for diffusion of small amounts, multiplication of the bac­
teria had occurred and the degree of infection had increased enor­
mously and the infection had become widespread before the serum 
became effective at the site of injection. Our experiments suggest 
that in the action of immune serum a body or tissue factor is essen­
tial, in addition to the substance contained in the serum. If the infec­
tion is not too great, this factor is adequate. If, however, the infection 
is enormous, this factor is no longer sufficient. Within given limits, 
however, any variations in this factor are not important and, more­
over within these limits the relation of serum to culture is fairly' 
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constant. This fact is of great importance, as upon its va�dity 
depends the possibility of establishing a standard of potency. 
From these experiments and tp.ose of Neufeld, it has b�en decided 
justifiable to fix a definite standard of strength to which sera used 
for therapeutic purposes should conform, determining this strength 
by direct estimations of the protective action of a definite fixed · 
amount of the serum for mice against variable amounts of culture of 
high virulence. In such estimations as these it is obvious that while 
variations in virulence are important, slight variations make no great 
difference, as they would in determination of the minimal lethal dose, 
provided that the virulence is near maximum. The amount of serum 
to be employed in the tests also is not of great.importance, provided 
that it is always the same and provided that it is selected within 
the limits where the law of multiple proportions holds valid. 
Theoretically, it would be better to titrate several amounts of serum 
against varying amounts of culture, choosing these amounts of serum 
at various levels. Practically, however, this would render the 
method too complicated for ordinary use, and it has been found suffi­
cient to use one amount of serum, provided that this amount is not 
too great or too small, and that the same amount is used for all tests. 
Neufeld (17) used 0.2 cc. of serum for this purpose and we have 
found this satisfactory. Wadsworth and Kirkbride (30) have recom­
mended using 0.1 cc. of serum without, however, giving any definite 
reasons for the change. Since much work has already been done 
using 0.2 cc., it seems best to continue this method. 
We realize that the method of standardization w)rich we advise is 
far from ideal. At the present time, however, it seems to be the 
only practical one, and., if applied with care and attention to details, 
it will at least prevent the use of sera of low potency, and, we be­
lieve, will make the therapeutic use of antipneumococcic serum both 
possible and effective. 
Technique of Standardization Test.-In making a practical test of the 
protective power of the serum, white mice weighing 18 to 22 gm. are 
employed. The largest amount of an 18 hour broth culture of the 
homologous pneumococcus against which a constant quantity of 
the serum, 0.2 cc., will protect, is determined. Various dilutions 
of the broth culture are so prepared that each 0.5 cc. of the mixtures 
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contains a given quantity of the pneumococcus culture, from 0.2 cc. 
to 0.0000001 cc. The dilutions are made in peptone broth similar 
to that in which the bacteria are grown, and a separate pipette is 
used for making each dilution in order that an accurate distribution 
of the bacteria may be obtained, and to avoid ca1Tying over any 
bacteria from the lower to the higher dilutions. The dilutions are 
made immediately before being used so that do growth or other change 
may occur in the mixtures. At the sai::ne time a small amount of 
the serum is diluted in broth, two parts of serum .to three of broth, 
so that 0.2 cc. of serum is contained in each 0.5 cc. of the mixture. 
Whe}) injecting the animal, 0.5 cc. of the diluted serum is taken up 
into a 2 cc. Luer syringe and then 0.5 cc. of the diluted culture which 
is to b� injected. The mixture of serum and culture is then injected 
at once intraperitoneally. The needle of the syringe is run under the skin a little above and parallel to Poupart's ligament and then ob­
liquely through the abdominal wall. By this method injury to the 
liver, large blood vessels, or kidneys is avoided. In making a test 
of a given amount of serum, usually injections are made of 0.2� 
0.1, 0.01, 0.001, and 0.0001 cc. of culture, each mixed with 0.2 cc. 
of the serum to. be tested. It is best to inject "two mice with each of 
these amounts. In making the series of injections one should com­
mence with the mixtures containing the smallest amount of culture. 
It is then possible to use one syringe for all the injections. As a con­
trol of the virulence of the organisms used, another series of mice 
should be injected with these dilutions of culture, each with 0.2 cc. of 
the standard serum. Any marked variations in the virulence of 
the organism employed will then become evident, since by the protec­tive power of the standard serum against the culture of organism em­
ployed, the virulence of the latter may be estimated. As a' further 
control of the virulence of the organism, three mice are injected in­
traperitoneally, one receiving 0.0000001 cc., one 0.000001 cc., and 
one 0.00001 cc. of culture. The actual number of organisms contained 
in the culture employed is determined· by making agar plates from each of these dilutions of culture and estimating the number of colo­
nies appearing after 24 hours' incubation. With the same proportion 
of peptone in the broth and a standard acidity, it is surprising how 
nearly equal the numbers of bacteria contained in 1 cc. of each of the-
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various cultures are. Usually 0.0000001 cc. of culture gives rise to 10 
to 30 colonies on the plate, which means that the number of bacteria 
contained in 1 cc. of the broth culture is from 100 to 300 million. 
It is our plan to mark the mice by staining a given part with carmine, 
and it is well to have a regular system for doing this and marking 
each animal before it is released from the hand. As the mice are 
injected, they are placed in glass jars containing sawdust and covered 
with pieces of wire netting. Care should be taken that they are 
not overcrowded (not more than three or four mice in a jar) and they 
should be kept in a room with an even temperature. They should be 
observed over a period of 5 days. With a virulent pneumococcus the 
controls, receiving culture· alone, should die within 48 hours. These 
mice, as well as those unprotected by the serum, should haye cul­
tures made from the heart's blood in order to make sure that pneu­
mococci are present and that some extraneous factor has not been the 
cause of death. 
The best Type I sera that we have been able to produce have 
not protected regularly against doses higher than 0.2 to 0.5 cc. of 
culture. Most of them have not protected regularly against doses 
over 0.2 cc. We beJ!eve, therefore, that for therapeutic use only 
those sera should be employed which in doses of 0.2 cc. protect regu­
larly against at least 0.1 cc. of a culture which is shown by the ani­
mal and standard serum tests to be of proper virulence. The viru­
lence of the organism used in the protection test is usually such that 
0.000001 cc. of an 18 hour broth culture will kill a mouse of 20 gm. 
weight within 48 hours. The following protocol illustrates the exact 
method of carrying out the test: 
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Typical Protocol of Standardization Test. 
Marked. Culturl!- Scrum. 
Serum, Horse XX, Lot 4. 
cc. cc. 
Head. 0.2 0.2 " 0.2 0.2 
Back.. 0.1 0.2 " 0.1 0.2 
Right hind leg. 0.01 0.2 
" " " 0.01 0.2 
Left " " 0.001 0.2 
" " " 0.001 0.2 
Right fore " 0.0001 0.2 
" " " 0.0001 0.2 
Standard serum. 
Head. 0.5 0.2 
Back. 0.4 0.2 
Right hind leg. 0.3 0.2 
Left " " 0.2 0.2 
Right fore " 0.1 0.2 
Left " " 0.01 0.2 
Head. 0.00001 -
Back. 0.000001 -
Right hind leg. 0.0000001 -
* D., died; S., survived.
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Result. 
D.* 48 hts. 
s. 5 days.
s. 5 " 
s. 5 " 
s. 5 " 
s. 5 " 
s. 5 " 
s. 5 " 
s. 5 " 




s. 5 " 
s. 5 " 
s .. 5 " 
D. 12 hrs.
D. 24 " 
D. 36 " 
In our experience sera produced by the injection of Type II or­
ganisms never regularly protect higher than in the ratio of 0.2 cc. of
serum to 0.01 cc. of culture. The protective power of Type III serum
is still less. 
SERUM TREATMENT. 
Indications Jor Serum Treatnient. 
11t has been proposed by others that immediately after admission 
to a hospital or after coming under the care of a physician and before 
the type of infection is determined, every patient should receive a 
large dose of antipneumococcic serum of Type I or a polyvalent 
serum containing antibodies to Type I pneumococcus. The purpose 
of employing this method i6 to avoid the delay incident to the de­
termination of the nature of the infection. Later, if the infection 
proves t<:> be due to Type I pneumococcus, the treatment may be 
continued; otherwise it may be stopped. As we shall show later, the 
administration of serum is frequently followed by general constitu­
tional reactions and, if this method were employed, many patients 
in whom the serum could be of no possible value would be subjected 
to these reactions. The time gained would not be great, since, in 
most cases, the type of infection can be determined within 6 to 18 
hours, and during this time, if the patient is sensitive to horse serum, 
he can be des�nsitized. Pneumonia is the easiest of the acute infec­
tious diseases to diagnose. If the importance of early diagnosis and of 
type determinations were generally recognized, serum treatment could 
be commenced very early in most patients, even though the etiologic 
diagnosis caused slight delay. We therefore believe that except in 
emergencies the administration of serum should only follow the 
determination of the nature of the infection. 
As soon as the type of pneumococcus responsible for the infection 
has been determined, if it proves to be Type I, serum treatment 
should be undertaken at once in all cases, except in very young chil­
dren who appear but little intoxicated by the infection and in whom 
the prognosis is good and the difficulty of treatment great. In
the case of adults, first seen late· in the disease, apparently mildly 
�11, and already showing signs of decreasing fever and intoxication, 
serum treatment may also be unnecessary. When cases are seen late 
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in the disease, still very ill, one should be extremely careful to elimi­
nate complications as the cause of the symptoms. The value of the 
intravenous use of antipneumococcic'serum in otitis media, empyema, 
pelvic or joint abscesses, pneumococcus pericarditis, or meningeal in­
fections h�s not been demonstrated. Occasionally one is tempted not 
to use serum, or at least to wait a day or two, in cases which seem 
relatively mild at onset. This is believed to be most unwise, as fre­
quently the pathologic process spreads insidiously, giving little evi­
dence of intoxication for several days, when suddenly the picture 
changes, the pulse, temperature, and respiration rise, cyanosis deepens, 
and the end comes too soon to be influenced by the tardy use of the 
specific serum. 
Occasionally one first sees a case at a time when consolidation of an­
other lobe is taking place. At such a time the temperature may 
perhaps be lower and the heart rate and respirations slightly less 
rapid than previously. On the other hand, the general appearance 
. . 
of the patient does not seem reassuring; he may appear prostrated, 
and the extremities may be moist and clammy. In a few hours the 
temperature rises again, and the following day the signs of more exten­
sive consolidation may be more apparent. These cases especially need 
immediate treatment when first seen if the further spread of the 
disease is to be prevented. 
Administration of Serum. 
Antipneumococcic serum can be administered most easily in a 
hospital where trained assistants and sterile materials are always 
available, but it may be given anywhere, in the home or in the field, 
in fact wherever water can be boiled and iodine and alcohol 
obtained. 
Following the administration of foreign serum, especially the large 
amounts necessary in this form of therapy, the patient may exhibit 
certain symptoms which are entirely due to the foreign ·protein and 
have nothing to do with the content of the serum in antibodies. 
This reaction is identical with, or at least analogous to the so called 
anaphylactic reactions· seen in animals. It is very important that, 
before serum is administered, every effort should be made to ascertain 
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whether patients are highly sensitive to horse serum, in order that 
such reactions may be guarded against. The detection of serum 
sensitiveness is not difficult. Every patient with pneu�onia, imme­
diately on admission to the hospital or after coming under-the physi� 
clan's care, should receive proper tests to determine this fact, since, 
if he proves to be infected with Type I pneumococcus, serum should 
be administered. 
The patient is first questioned for a history of previous injections 
of immune sera for diphtheria, meningitis, or for tetanus infections. 
He is also questioned concerning previous symptoms suggesting 
asthma or hay fever, since, persons having such symptoms are likely 
to be sensitive to various proteins, including those in serum. In any 
event, however, an intradermal skin test is performed. 
Intradermal Skin Test.-The skin, preferably over the forearm, 
is carefully cleaned with soap and water and alcohol, 'taking care 
not to make the skin red or inflamed. If the skin is gently patted, 
instead of rubbed, with a gauze sponge, no irritation develops. With 
a small syringe, preferably of the type used for tuberculin injections, 
and a :fine needle, about No. 28 gauge, 0.02 cc. of 'sterile diluted horse 
serum (normal or immune), diluted with salt solution 1 :10, is in­
jected into the skin, not subcutaneously, so that a small white wheal 
about 3 mm. in diameter showing the little depressions of the hair 
follicles is produced. An injection of a like amount of sterile salt 
solution is made as a control. It is advisable to make the serum and 
the control injections at one level on the forearm, about 3 to 4 cm. 
apart, in order that the test may not be obscured by the possible 
spreading of the injected material along the lymphatics. 
The points of injection should be observed at intervals for 1 hour. 
Usually after a few minutes the wheal p.roduced by the salt solution 
disappears, leaving no alteration in the skin except the small needle 
puncture. If the test is negative, that is, if no evidence is obtained 
of horse serum sensitiveness, the wheal produced by the s�rum in­
jection fades away also almost a.s rapidly. On the other hand, if 
sensitiveness does exist, usually within 5 minutes a genuine urticaria! 
wheal begins to develop, which may increase slowly in size up to 
that of a half dollar; the wheal in turn being surrounded by a larger 
area of erythema. This lesion usually reaches its m�ximum extent 
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within 1 hour and fades away rapidly, disappearing entirely within 
a few hours. A faint erythema, may persist for a day or more. 
There are usually no subjective symptoms from this intradermal injec­
tion, except occasionally slight itching at the point of injection. Very 
rarely, in individuals extremely sensitive to horse serum, the in­
jection of this small amount of serum, 0.002 cc., has been known to 
produce general symptoms, flushing of the face, increased rapidity 
of the heart rate, and respiratory discomfort. 
Desensitization.-It has been shown that even very susceptible 
and highly sensitized animals may be completely desensitized, so 
that they can tolerate large amounts of the serum to which they are 
sensitive, if repeated injections are made, beginning with an ex­
tremely minute dose and following this with doses of gradually 
increasing size. Even administering the serum with extreme slow­
ness may be sufficient to prevent anaphylactic shock, or the adminis­
tration of a very small dose, several hours before the large injection, 
may protect animals that are not highly sensitive. Therefore, 
for purposes of desensitization, it is advi,sabl� to. inject' 0.5 to 
1 cc. of a.ntipneumococcic serwn or sterile normal horse serum sub­
cutaneously into every pneumonia patient as soon as the skin test is 
completed, even though the intradermal skin test is negative, for 
occasionally one sees a patient in whom the skin test appears to be 
negative and yet in whom, on the injection of large amounts of serum, 
slight symptoms of serum sensitiveness appear. It is believed that 
the subcutaneous injection of a small dose of serum will desensitize 
a patient for from 6 to 8 hours to several days. However, this pro­
cedure should not be relied upon to the extent of giving the subse­
quent intravenous dose at a rapid rate. We know of at least one 
instance in which a desensitizing dose of 1 cc. of serum injected sub­
cutaneously failed to prevent the development of a severe anaphy­
lactic reaction in a patient who had received an intravenous dose of 
.serum 10 days before. In our hands, however, the use of the pre­
liminary intra.dermal and subcutaneous serum injections, we believe, 
has contributed much to our freedom from untoward symptoms 
during or after serum treatment. 
If the intradermal skin test is positive, indicating that the patient 
is sensitive to horse serum and if the infection is due to Type I pneu-
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mococcus, in which case the patient should receive serum treatment, 
a more thorough method for desensitization must be employed. This 
should consist in giving extremely small amounts of serum subcu­
taneously at ½ hour intervals, doubling the size of the dose at each 
injection. One can safely begin with the injection of 0.025 cc. of 
serum. If no reaction follows the injection of 1 cc., subsequent 
doses may be given intravenously, also at½ hour intervals, beginning 
with 0.1 cc. and doubling the dose at each injection. If a general 
reaction occurs, or cyanosis, dyspnea, or increased rapidity of the 
heart rate supervenes, the injections should be suspended for 2 to 4 
hours, depending upon the severity of the reaction, and then be 
resumed, starting with the same dose as that producing the reaction. 
After 25 cc. of serum have been given· in these small doses, after a 
lapse of 4 hours, 50 cc. may be given, followed by the regular dose 6 
to 8 hours later. The desensitization of a patient is a tedious and 
time-consuming procedure. Fortunately one rarely is called upon 
to employ this measure. It has been found necessary to desensi­
tize in this way only two or three patients in a series of over 150 cases. 
Technique of Treatmerit.-In preparing for the intravenous in­
jection of serum it is best, though not necessary, to have a sterile 
field; that is, sterile towels, gloves, etc. It is, however, quite possible 
to inject ·serum aseptically with only a package of sterile gauze 
sponges and iodine and alcohol to disinfect the patient's skin about 
the point of injection. The apparatus for injecting the serum is shown 
in Text-fig. 2 and consists of the following: 
1. Sterile contai�er for mixture of antipneumococcic serum and sterile freshly 
distilled normal salt solution. 
2. Rubber tubing, 4 feet long, and a three-way stop-cock.
3. Short piece of glass tubing for a window.
4. Rubber stopper with double holes through which are thrust two pieces of
glass tubing. One tube is long enough to reach nearly to the bottom of the 
container, and through this air enters the container when the latter is inverted. 
The other shorter glass tube forms the outlet for the serum. 
5. Two sharp needles a.lid needle holder.
6. One 20 cc. Luer all glass syringe.
7. One 2 cc. Luer all glass syringe with hypodermic needles.
8. Thumb forceps.
9. Medicine glass.




TEXT-FIG. 2. Apparatus·for injection of serum. 
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All' this apparatus should be· assembled and sterilized by boiling 
for 20 minutes in a covered dish. It is important to rinse· out 
the tubing thoroughly after it has been -used; otherwise with a sub­
sequent steri�zation any serum remaining in the tubing will be coagu-
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lated and plug the apparatus. This material in the tubing may also 
be responsible for unexpected reactions on the part of the patient 
when it is accidentally injected along with the serum. To avoid 
this difficulty, the rubber tubing may be almost entirely replaced by 
lengths of glass tubing short enough to be contained in the sterilizing 
receptacle. These are connected by short pieces of rubber tubing 2 
inches long, which are easily cleaned and can frequently be discarded 
for fresh ones. The serum should be warmed before injection to 
slightly above body temperature. It has been customary to dilute 
the antipneumococcic serum with equal parts of sterile freshly dis­
tilled (glass still) salt solution just before the injection is made. 
This makes the serum less viscous and facilitates its flow through 
the tubing. If salt solution properly prepared for intravenous use 
cannot be obtained, the serum may be used in its undiluted condition. 
The slow injection of the smaller amount of fluid during 25 to 30 
minutes is, however; somewhat difficult. 
When one is ready to make the injection, the serum is transferred to 
the container by means of a sterile pipette. In this way the trans­
ference of the small amount of sediment which is always present in 
the bottom of the bottle (if care has been taken to prevent shaking) 
can be avoided. If no pipette is at hand, the serum may be carefully 
poured from the bottle to the container, taking care that the sediment 
is not disturbed. This sediment may do no special harm, but its 
administration should be avoided if possible. When no container 
is available, the serum may be injected directly from the bottle, with 
a syringe with a long needle. The method described1 however, is 
the one of choice. 
Having filled the container, the cork is inserted and prevented 
from falling out by st.rips of adhesive tape. The bottle is inverted 
and attached to the side of the bed or to an irrigating stand. After 
allowing the serum to fill the tubing, the needle is introduced into 
a convenient vein, usually at the bend of the elbow, the overlying 
skin being previously cleansed with iodine and alcohol. If one has 
facilities for making blood cultures, it is wise to take about 10 to 15 cc. 
of blood for blood culture before beginning the serum injection. The 
serum may be allowed to run into the vein very slowly by gravity, 
but may be more easily and accurately controlled by aspirating it 
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�to the syringe and then in turn injecting it into the vein (Fig. 5). 
In this way it is possible, and indeed advisable, that the steady and 
sl9w injection of the first 10 to 15 cc. of serum should occupy 10 to 
15 minutes. During this period one watches carefully for any change 
in the patient's appearance and for increased rapidity of the pulse, 
respiratory difficulty, pallor, cyanosis,or urticaria. If these symptoms 
appear, it is well to stop the injection of serum for a few minutes, 15 
to 20, to see if the symptoms increase in severity. Usually they 
rapidly disappear and the injection can be resumed. The needle 
can be easily kept free from dots by slowly injecting salt solution with 
the detached syringe. The serum can be kept at about body tem­
perature when being injected slowly by placing the tubing between 
two hQt water bags just before it reaches the patient. 
Except in very rare instances, no symptoms arise during the in­
jection of the first 10 or 15 cc. of serum, and the injection may then 
be completed more rapidly in 10 to 15 minutes. As soon as the needle 
is in the vein and is kept motionless, the patient experiences no dis­
comfort; in fact, in most cases the patient dozes' quietly during the 
treatment. With nervous individuals, the infiltration of a small 
area of-the skin at the point of injection with 1 per cent cocaine or 
novocaine solution renders the whole procedure painless. 
Dosage and Frequency of Treatment$. 
Practical experience has now shown that for antipneumococcic 
serum to be effective it must be given in large doses and intrave­
nously, in order that a wide distribution of immune bodies throughout 
the body may occur rapidly. As previously stated, the exact mode 
of action of the serum is not yet certain; nevertheless to obtain satis­
factory results, it is necessary to inject sufficient serum to produce 
in the patient's blood a concentration of antibodies such as that which 
occurs during natural recovery from. the disease, for we believe 
that it is largely upon this factor that recovery depends (15, R32). 
If to obtain- this result required merely the addition of a definite 
amount of the serum to the patient's blood, just as we might 
make a dilution of the serum in normal blood in the test-tube, there 
would be little difficulty. However, experiments have shown that (R 
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30) not only do the bacteria circulating in the blood fix antibodies and
so render them ineffective, but in the infected patients the blood
contains soluble substances which fix antibodies ju.st as do _the
bacteria themselves. In the severely infected patients these soluble
substances may be present in very-large amounts, and it is only after
these substances are all saturated that an effective concentration of
immune bodies in the blood can be obtained. Moreover, it is not
only necessary that the desired concentration of antibodies should
be present immediately following the injection, but also that this con­
centration should be maintained. We have shown that as soon as this
object is accomplished, unless the infection has lasted too long and
has become too great, there occurs a fall of temperature and recovery
from the disease.
The amount of serum necessary, therefore, will vary in each case. 
At present we have no means of deciding in the individual case what 
the primary dose should be. Neufeld, on the basis of the theory of 
Schwellenwert, decided that in the average man the dose should be 
about 75 cc. We also think the dpse should be large and, from our 
experience and from the observations concerning· neutralizing sub­
stances in the blood of infected patients, we have established more or 
less arbitrarily an initial dose of our standard serum of 90 to 100 cc. 
The frequency and size of the succeeding doses must be regulated 
largely by the effects obtained from those preceding. It was hoped 
that it might be possible to regulate the succeeding doses by determin­
ing the antibody content of the patient's blood at frequent intervals. 
This procedure is too complicated to be carried out regularly, even in 
hospitals that are best equipped for such work. In others this method 
is absolutely impossible. We must therefore be guided by the experi­
ence already gained from the careful study of a series of cases. We 
have concluded from these studies that it is extremely important that 
once having start�d specific treatment, it should be continued until a 
definite favorable result has been obtained and, in order to accomplish 
this, the serum should be given every 8 hours in doses of 90 to 100 cc. 
unless there are indications to the contrary. Our experience has 
indicated that the total amount of serum required may be diminished 
by active and persistent treatment at the start. The average total 
amount of serum required in our cases treated during the past winter 
has been about 250 cc. 
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In a considerable number of cases, within 20 minutes to an hour 
following the injection of serum there occurs an elevation of tempera-
ture, followed by a marked fal.J. This is described in the following 
pages as the so called thermal reaction. If the temperature con- · 
tinues low and the patient's condition is good, no further administra­
tion of serum is necijssary. These patients, however, must be very 
careful1y watched. The temperature should be taken every 2 hours 
and, if the temperature during the next 24 hours rises to 102°F. or 
over, a second dose of serum should·at once be administered. If no 
fall of temperature occurs following the first dose, or if it does not 
fall to 102°F. within 8 hours, the second dose of serum should then be 
given. It is obvfous that this rule should not be absolutely hard 
and fast, for the temperature is not the only guide to the patient's 
condition. However, it is better to err on the side of giving the serum 
too soon than of delaying too long. 
·n, following the second dose of serum, no reaction occurs, within
8 hours another similar dose should be administered, and this should 
be repeated as often as necessary. The patient should be observed! 
day and night and the treatments should be given at night as well as 
by day whenever necessary. In the cases in which no re.action is 
obtained after several doses of serum, great care must be exercised 
to detect the presence of complications such as empyema or otitis 
media, to which the persistence of temperature may be due and on 
which the failure of the serum to act depends. 
Serum Reactions. 
The injection of serum may be followed by several types of reaction; 
first, the true anaphylactic reaction, second, the so called thermal 
reaction, and :finally, usually at a later period, the symptom complex 
called serum sickness or serum disease. 
Anaphylactic Reaction.-In individuals who are sensitive t.o horse 
·serum, there may develop at once or within 15 or 20 minutes after
the introduction of 40 to 100 cc. of serum, a more or less sev�re
asthmatic attack with dyspnea and flushing of the face, followed by
· cyanosis, sweating, cough, and general anxiety, and an urticaria!
eruption. Method� have previously been described by which these
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reactions can be avoided. According to Walker (31), however, 
- reactions may occur, though very rarely, even in patients who have
not reacted positivelyto horse serum and who have received a sub­
cutaneous desensitizing dose. He has found that these individuals,
though not sensitive to horse serum by the usual test, are very sensi­
tive to the proteins in horse hair and horse dandruff. In these
unusual cases small do.ses of horse serum produce no reaction, but
doses of over 40 to 50 cc. of serum seem to induce a true anaphylactic
attack. In these cases the :first dose of serum usually produces com­
plete desensitization and, following a second dose, even a very large
one, no reaction of this type occurs. An anaphylactic reaction; un­
less extremely severe, is usually quickly relieved by �he hypodermic
injection of 0.6 cc. of epinephrin (1: 1,000) solution or 0.5 mg. of
atropine sulfate, or both.
It is the consensus of opinion among those who have had large
experience in the administration of serum that severe anaphylactic
reactions occur with great rarity, even when precautions have
not been taken to avoid them. If all the precautions we have men­
tioned are taken, serious anaphylactic shock will probably never
occur. The administration of antipneumococcic serum should
never be neglected or omitted because of the remote possibility of
the occurrence of these reactions.
Thermal Reaction.-Another type of reaction, that which follows
the intravenous injection of various foreign proteins, the so called
thermal reaction, appears usually from 20 minutes to 1 hour after the
injection, and is characterized by chilly sensations or a general shak­
ing chill, slight difficulty in breathing, and cyanosis. The temperature
rises rapidly 1-3°F. and then falls, often to normal. During this fall
there may be profuse perspiration. The patient usually rests quietly
after a reaction and the general physical appearance seems improved.
These reactions apparently have nothing to do with anaphylax:is or
previous sensitization and may occur following the first dose of serum
or following subsequent doses. · Frequently the temperature remains
normal, but in other cases after 6 to 24 hours the temperature again
becomes elevated. It is this type of reaction which sometimes occurs
· following the administration of large doses of vaccines, and in such
cases has been thought by some to have therapeutic value. We have
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never felt that this reaction in itself is of benefit to the patient and 
believe that it should be avoided if. possible. In certain instances 
administration of the serum too rapidly or the administxation of cold 
serum may be responsible. Little treatment for this type of reaction 
need be given, reassurance, the application of heat to the extremities, 
and warm drinks being sufficient. 
Serum Disease.-Following the administration of foreign serum, 
there frequently occurs a group of symptoms which together are 
called serum disease or serum sickness. The symptoms are fever, 
skin rashes, most frequently urticaria or erythema, edema of the 
skin, general glandular enlargement, and pains in the joints, and the 
symptoms may appear individually or in combination. The typical or 
most characteristic serum disease consists of all or most of the symp­
toms appearing together 7 to 14 days following the administra­
tion of serum, the attack lasting a few days to a week or more. The 
attacks may recur one or more times at intervals of a few days to a 
week or even longer. Such a typical and fairly well marked disease 
is not the rule, however. In most cases the course is extremely 
irregular. Certain of the symptoms, chiefly the skin rashes; may 
appear very early, within a day or a few days following the administra­
tion of serum. Later other symptoms may appear, singly or together. 
And these symptoms may reappear or persist irregularly for a month 
or more. Not all cases receiving serum show the symptoms. 
Mild symptoms of the disease appear in only about half of the treated 
cases, severe attacks only rarely or in not more than 10 per cent 
of the cases. The severity of the symptoms is not directly propor­
tional to the amount of serum received, though undoubtedly the 
severe cases are more likely to occur in the patients that have re­
ceived large doses of serum. 
The fever in the mild cases may be very slight, hardly noticeable. 
In the severe cases it may· be high, even reaching, exceptionally, 
104° or 105°F. The cases with fever may cause much anxiety to the 
physician, since he is frequently in doubt as to whether the serum 
reaction is responsible for the fever or whether the fever is due to some 
complication. During the entire period of convalescence the phy· 
sician should always be on his guard and, while he should realize 
that serum sickness may be accompanied by marked symptoms and 
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elevation of temperature, he should remember that it is unsafe to 
ascribe all unu,sual symptoms occurring during this period to serum 
disease. When fever occurs, frequent Roentgenographic examinations 
should be made to detect the presence of delayed resoiution or the 
appearance of flu.id in the chest. The occurrence of otitis media 
or localized infection should be looked for carefully. If the fever is 
due to serum disease, the patient does not usually appear very ill, 
as would be the case if the fever were associated with some focal 
complication with pus formation. The pulse is relatively Jess rapid, 
sweating is uncommon, and the appetite is good. The leukocyte 
count often helps in the differential diagnosis. While the total leuko­
cyte count may be moderately elevated in serum sickness, up to 
15,000 to 20,000, there is usually an increase in the relative number of 
lymphocytes, 30 to 40 per cent, and frequently the number of eosino-
phils is slightly increased, 3 to 7 per cent. 
The skin rash may consist of only a few urticaria! wheals appearing 
intermittently, or it may be widespread and consist of a diffuse 
erythema, even scarletinifo�, or it may be more irregular, suggest­
ing measles. When the urticaria is extensive, pruritus may be 
very marked. This is usually the most distress�ng symptom. It 
may be relieved to some extent by allowing the patient to have a 
bottle of calamine lotion by the bedside which he applies to the itch­
ing areas as desired. Some such formula as the following may be 
used: 
Carbolic acid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 cc. 
Calamine ........ : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 gm. 
Zinc oxide. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 " 
Glycerol .................................................. 12 cc. 
Lime-water. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 " 
Water up to� ............................................. 120 " 
With this lotion the patient can usually be kept fairly comfortable 
during the day. At night the use of epinephrin hypoden:µ.atically, in doses of 0.6 to 1 cc., has been found useful. Following the 
injection the urticaria disappears like magic for a few minutes to 
a few hours, when it again returns. If one .uses epinephrin at night, 
the patient wilJ often fall asleep as soon as the urticaria disappears 
and will sleep several hours before being disturbed by the itching. 
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Occasionally there may be considerable edema present with the 
skin rash, or it may occur independently. It is most common about 
the face and neck and it may be so extensive as to close the eyes. 
This usually lasts only a few hours. 
During the course of serum sickness there usual1y occurs slight 
enlargement of the superficial lymph glands.. Somethµes only a 
few of the glands are enlarged; at other times the enlargement is 
general. The spleen may also become palpable, th�ugh this is not 
the rule. Occasionally the cervical glands beneath the sternomastoid 
muscle may become so enlarged and tender as to suggest a pyogenic 
infection, but this condition usually completely disappears in 2 or 3 
days. 
There is rarely nausea or vomiting. Very rarely acute abdominal 
pain may be complained of. There is no localized tenderness or 
rigidity, however, and this condition is usually transitory. 
During the serum sickness, as von Pirquet and Schick (22) have 
noted, a disturbance of kidney function may be present. Longcope 
(11) found that about 10 per cent of his carefully studied cases
showed albuminuria and hyaline and granular casts in the urine.
There is little change in the coefficient of urea excretion or in the
phthalein output. The excretion of water and chlorides is, however,
profoundly affected, both being rapidly diminished with the onset of
the sickness. This change in renal function is transitory and the
return to normal is usually rapid.
Accompanying the other symptoms there may develop stiffness in 
the joints. The process seems to be extra-articular. There is rarely, 
if ever, any fluid in the joints, nor is the skin hot or reddened. There 
may be ·a slight amount of edema about the joints. All the joints 
may be attacked or only one or two. A joint- frequently affected 
is the temporomandibular, and this causes considerable annoyance 
to the patient. Usually the joint symptoms pass away in a few days, but may last a week. The administration of aspirin or sodium 
salicylate and sodium bicarbonate usually gives relief from the dis­
comfort. 0.3 to 0.6 gm. of the salicylate with 1 gm. of sodium bi­
carbonate may be given every 4 to 6 hours. Occasionally the patient 
complains of a headache which may persist for several days, but 
this is usually relieved by aspirin. 
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As previously stated, serum sickness may be very mild or it may be 
prolonged and troublesome, and the joint pains and urticaria may 
cause considerable distress. As far as we know, howev�r, it is never 
serious, and leaves no permanent bad effects. Von Pirquet and 
Schick, whose monograph contains the best description of the disease, 
report no fatal cases, and we have never seen any serious effects, 
even in the worst cases. The fact that serum sickness may possibly 
occur should never deter the physician from giving serum. If life 
can be saved, the occasional occurrence of troublesome symptoms in 
a few patients is of little· importance. 
Supplementary Therapeutic Measures. 
General Measures .-In addition to the specific therapy advised in 
the treatment of Pneumococcus Type I infections, the general hygienic 
and therapeutic management of the case must not be neglected. 
It is extremely important that the patient should be nursed, rather 
than nurse himself, from the onset of the infection. The prognosis 
in individuals who have pursued an ambulatory course during the 
first few days of the disease is distinctly worse. If transfer to a 
hospital is to be made, the patient should not be allowed to dress and 
walk to the ambulance, no matter how mild the infection may seem. 
Where impossible to move in the horizontal position, the transfer 
may be made semi-reclining in a chair. Even this exertion is often 
exhausting. The patient should not be allowed to help himself 
to food or drink, or to bedpans. The strict enforcement of these 
precautions plays an important part in the patient's recovery. 
Diet.-The diet during the acute course of the disease is relatively 
unimportant. In general it should be fluid, easy to swallow and 
digest. Pure.es and soft boiled eggs, in addition to liquids, may be 
given if the patient desires them. In some cases whisky in small 
amounts may be beneficial. Water, 3,000 cc. or more a day, should 
be conscientiously given. 
Treatment for Abdominal Distention.-The routine use of a daily 
morning enema of soap-suds aids in preventing this complication. 
Distention most frequently occurs in the severely intoxicated cases. 
It can frequently be controlled by proper diet, stupes, and medi-
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cated enemata. If abdominal distention occurs, milk should be tem­
porarily eliminated from the diet. Stupes may be conveniently given 
by applying compresses soaked in olive oil mixed with turpentine, 
1 part of turpentine to 3 parts of oil, and covering with flannels 
wrung out in as hot water as the patient can tolerate, the heat being 
retained by a thick pad. The hot flannels should be changed fre­
quently for a period of 20 minutes. A rectal tube may be inserted 
to aid in the passage of gas. This entire procedure is repeated at 
20 minute intervals. To be effective, the applicatibn of stupes 
must be continued for a long period. Following their application, 
medicated enemata may be used. A very effective enema is one 
composed of ox gall 4 cc., turpentine 8 cc., asafetida 12 cc. This 
combination is diluted in 1 to 2 pints of soap-suds and is followed 
in 1 hour by a soap-suds enema. Usually this is effective in relieving 
the distention, at least for a short time. Some cases are temporarily 
benefited by the hypodermic use of pituitrin in doses of 0.5 cc. 
Di,gitalis .-The experimental work of Porter and his coworkers 
(23) tends to show that the heart muscle is not vitally injured
in pneumonia and that respiration usually fails before the circulation.
Cohn (Rl 7) has found that the pneumonic heart can be influenced
by digitalis in quite the same way and by approximately the same
dosage as the normal heart. Consequently it has been our custom to
use some form of digitalis as a routine. On account of the convenience
of administration and its accurate standardization, digipuratum has
been used at the Hospital of The �ock.efeller Institute, though any
standardized form of digitalis may be used in corresponding doses.
It is extremely important that the use of digitalis should be commenced
early in the disease in all patients, in order that they may be partly
digitalized before an immediate need arises. The intravenous use of
digitalis or strophanthin is thereby avoided. The intravenous injec­
tion of these drugs may give rise to very serious symptoms, especially
if the patient has previously received digitalis. Under this con­
dition these drugs should never be injected into the vein. If patients
are treated early, they are given 1 gm. of digipuratum at the rate of 0.5
gm. a day by mouth. If they are not seen until late in th\ disease and
appear quite ill, 1 gm. is given on the first day. With this dosage there
is usually evidence of the he�rt muscle being digitalized in about 24
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hours. If the patient's condition does not indicate its further use, 
the drug is discontinued. If, ho�ever, occasion arises for digitalis 
later in the disease, it is again given at the rate of 0.5 gm: a day until 
the indication is satisfied, but it is not usually continued beyond 2 
gm. The beneficial effects of the use of digitalis are best seen in 
cases of collapse, in which the pulse rate often rises to 150 to 180. 
This rise is usually due to flutter or fibrillation of the auricles. In 
these cases digitalis acts by blocking the irregular and frequent 
auricular impulses, so that often the ventricular rate falls below the 
initial rate and the symptoms of collapse disappear. 
Optochin.-In 1911 Morgenroth and Levy (12) reported the dis­
covery of optochin (ethylhydrocuprein), a derivative of quinine, which 
was found to have a specific bactericidal action on pneumococci both 
in vitro and in vivo. The experimental studies led to great hopes 
that this drug might be found to have specific curative effects in 
patients suffering from pneumonia. Ex_tensive studies have been 
made on the drug in The Rockefeller Institute, both experimentally 
on animals by Moore (R43, R44, R45) and in the treatment of 
patients by Moore and Chesney (R12, R13). To our disappoint­
ment, however, in the treatment of 75 cases we have observed no 
definite beneficial effects. Because of this experience and owing to 
the danger of the drug producing injury to the eyes, the routine use of 
this drug in the treatment of acute lobar pneumonia cannot be 
recommended. 
Results of Serum Treatment. 
We shall here discuss only the effects of the administration of 
specific serum in the cases of lobar pneumonia due to infection with 
Type I pneumococcus. 
General E.ffects.-We have already discussed the so called thermal 
reaction which may immediately follow t.he administration of serum. 
The fall of temperature associated with this reaction· may be accom­
panied by amelioration of symptoms and the whole picture may 
present the features of a natural crisis. This occurs, however, in 
a small number of patients only. In other patients,· following the 
fall of temperature and the relief of symptoms which almost always 
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accompanies it, there may occur a return of symptoms and rise of 
temperature, though, if serum is again promptly administered, this 
practically never reaches its previous height. In other cases there 
is little immediate effect of the serum on the temperature or pulse. 
· In almost all cases, however, very soon after the administration of
serum the patient's general condition improves. This is not only
subjective, but is evident from the patient's, petter mental con­
dition and increased interest in his surroundings. The cyanosis
becomes less, and the pulse rate frequently falls. This phenomenon
strongly suggests that, in addition to its other effects, antipneumo­
coccic serum has a detoxifying effect. The exact nature of this effect
however, can only be surmised. Beginning with this general improve­
ment, unless the infection has been overwhelming, there occurs a
gradual lowering of temperature and pulse· rate, and amelioration
of the other symptoms, the patient usually returning to a normal
condition within a few days. What almost certainly happens fol­
lowing the administration of the serum is that the progress of the
disease is stopped. How rapidly complete recovery may occur de­
pends on numerous factors. That the progress of the qisease is
stopped if sufficient serum is given is made evident by the following'
facts, in addition to those just mentioned: First, in practically all
cases, following the administration of the serum, there has been no
extension of the local lesion. In certain cases in which the serum has
been administered early, sometimes only a very small portion of a
lobe has become consolidated. Second, invasion of the blood by
pneumococci has been prevented (page 35). Slight invasion of the
blood by bacteria probably always occurs at some time during the
disease, at least in all but the very mild cases. In the more severe
cases a true septicemia is usually present, and this always occurs
in the cases ending fatally. In our opinion the fatal outcome is
usually dependent upon this general infection. Now, in almost
every case in which we have administered serum and in which the
blood culture was positive before the administration of the serum,
one dose of serum, or at the most two, has resulted in the blood
becoming sterile. This fact seems to us of great importance .in.judging the efficacy of the serum. Third, following the administra­
tion of the serum, there appear in the patient's blood the immune•
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bodies which normally appear only at or about the time of crisis. 
It is possible, of course, that these immune bodies are only those 
contained in the serum administered. Whether the paiient himself 
is stimulated or permitted to produce immune bodies more rapidly 
or in greater numbers than would otherwise be the case is not known. 
We have previously stated (page 33) that the presence of precipitable 
substance in the urine is a bad prognostic sign. In several cases 
where the reaction was positive at the time the administration of 
serum was commenced, following the administration of serum the 
reaction became negative. 
Effect on Resolution and the Development of Complications.-The 
administration of serum apparently causes no change in the rate of 
resolution of the lung tissue already involved. This process is 
apparently independent of immunity reactions, and consolidation 
of the lung may persist even after the temperature is normal and the 
patient is, from a superficial examination, well. There is no evidence, 
however, that the occurrence of resolution is delayed or interfered 
with by the administration of serum. Complications, such as 
empyema, may occur even after the employment of serum. In 
certain cases the complications have already been present when 
the administration of serum has been commenced; in others the 
complication has undoubtedly appeared after this time. From a 
theoretic standpoint and from what we have learned from animal 
experiments, we might expect that the frequency of focal infections 
would be increased when serum treatment is employed. Infections , 
in susceptible animals are most likely to be focal when infection has 
occurred after the animals have been partially immunized, either 
actively or passively. Therefore if patients with severe infections 
which would otherwise be fatal are insufficiently treated with serum, 
it might be expected that, though the general infection is overcome 
and life is saved, focal infections might occur. Our statistics, how­
ever, do not show any increased frequency of complications among the 
treated cases. The non-specific treatment of cases with complications 
is exactly the same as though no serum had been given. Our empy­
ema cases have all been operated upon and all except one have
recovered. 
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Effect on Mortality.-The :final test of the effectiveness of immune· 
serum must rest on the evidence concerning the saving of lives. 
Although the number of cases so' far treated in the Hospital of The 
Rockefeller Institute is not large, the results obtained have been so­
striking that, taken in connection with the other evidence presented,.
· and supported, as they are, by the observations of others, they indi-­
cate almost certainly that the serum as employed by us has a marked
curative effect in the treatment of pneumonia of Type I. Up to the
present time 107 cases of lobar pneumonia ·of this type have been
treated with serum, and of these but 8 have died, 7 .5 per cent. When
this is contrasted with the mortality of 25 to 30 per cent, as observed.
in our cases before we commenced serum treatment and in the cases
observed elsewhere, the results obtained are definite and striking ..
During the past 5 years we have trea'ted with serum every Type I
case coming under our observation unless the case has been very mild
or unless the patient was admitted at a time when recovery had
obviously commenced. That the more severe cases were treated!.
with serum is shown by the fact that among 105 treated cases, the
blood cultures were positive before treatment was commenced in 40,.
or 38 per cent, while of 34 cases admitted during the same period and
in which no serum treatment was given, only 2 showed positive
blo�d cultures, or less than 6 per cent .
. In the fatal cases we have included e'very patient that received
serum, even a single dose. A brief statement as to these 'fatal cases
may be of interest. Three of the cases were treated only a few hours
before death, when they were desperately ill. One of the patients
recovered from the pneumonia, but died on the 16th day following a
pulmonary embolism. One patient was treated late in the disease
and later suffered from numerous complications, empyema, abscesses1 
etc., and :finally died on the 54th day from a general streptococcus.
infection. One patient had an extensive tuberculous involvement of
both lungs, with a very small area of fibrinous pneumonia in a part
of one lobe. The blood culture became negative and he apparently
recovered from the pneumococcus infection, and death was probably
'
1 due to the tuberculous disease. This leaves but two cases in which
the serum could possibly have been of use or in which any form of
specific treatment could probably have saved the lives. One of
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these cases was among the first ones treated by us and from our 
present knowledge was probably treated insufficiently. He was 
treated on the 5th and 6th days, dying on the latter day. The other 
case was one showing an extremely high grade of blood infection, 
300 colonies per cc., when he was admitted on the 6th day. In spite 
of this, with very vigorous serum treatment, he lived until the 12th 
day, but finally succumbed .. 
The results obtained by others in small series of cases in hospitals 
in New York, Boston, and Pittsburgh, where the treatment could 
be carried out with proper attention to details, have also been defi­
nite and satisfactory. Last fall on the Mexican Border Major 
Nichols (18) treated 63 cases occurring among the soldiers. Of these 
63 cases, 5 died, a mortality of 8 per cent. Among 18 cases with 
Type I infection not treated with serum, 7 died, a mortality of 39 
per cent. From his experience 'Major Nichols concluded that "no 
patient with Type I infection who dies without the early intravenous 
administration of large doses of Type I serum can be said to have 
received the best treatment." 
Cases Illustrating the Method of Treatment with Immune Serum. 
The following abstracts of cases and tempe�ature reactions illus­
trate some of the statements that have been made regarding treat­
ment and serum reactions. 
Case 1.-R. R., age 22 years, student (Text-fig. 3). This patient was admitted 
January 8 at 7. p.m., suffering from pneumonia involving the left lower lobe. 
The onset had been quite typical, with chill 48 hours before admission. He was 
moderatelysick, temperature 102.5°F.,pulse 115, respirations30,leukocytes31,000. 
Shortly after admission 0.5 cc. of horse serum was injected subcutaneously, but 
no previous intradermal test for serum sensitiveness had been made. The sputum 
was bloody; a small amount was at once injected into a mouse. The following 
morning tests made ·of the growth in the peritoneal cavity of the mouse showed 
that the patient was suffering from an infection with Type I pneumococcus. The 
blood culture taken on admission was positive, the plate showing 1 colony per 
cc. At 12.17 the intravenous injection of antipneumococcic serum was com­
menced. Although the serum was given slowly, after he had received about
35 cc. of serum he had some signs of serum intoxication, suffusion of face, some
r�iratory difficulty, and he vomited several times. The administration of
serum was therefore discontinued. He complained of tightness in the chest
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and a feeling of general weakness. 1 cc. of a 1: 1,000 solution of epinephrin was 
injected intravenously· and the patient's condition soon returned to normal, 
except that he sweated profusely. He was somewhat alarmed at what had 
taken place. His condition did not materially change during the afternoon, and 
at 5 p.m. serum was again administered, this time 80 cc., without any untoward 
symptoms. During the evening no definite change occurred in his condition. 
His temperature, however, had risen to 105.2°F. at 8 p.m., pulse 140, respirations 
40. Theref�re at 12 midnight anothe;r injection of 90 cc. of serum was made.
Following this injection the temperature rose to 196.2°, pulse 150, respirations
40. He had a shaking chill during which he became cyanosed. The tempera­
ture fell rapidly during the night and at 8 a.m. it was only 98.2°, pulse 108,
respirations 26. His color was good but he seemed rather weak and exhausted.
During the day his condition was excellent, but the temperature gradually rose,
reaching 101.8° at 8 p.m. He was then given another dose of serum, 100 cc.
There was no reaction of any kind following this injection. The temperature the
following morning was 99.4° and he felt quite well. There was no extension of
the process in the lungs and following this the patient made a good recovery.
During convalescence, however, he had quite severe serum sickness, the symptoms'
beginning 6 days following the last injection and sonie persisting for 2 weeks.
There occurred persistent urticaria, stiffness and pain in the joints, edema of the
face, and albumin and casts in the urine. He had some fever from January 20
to January 30, the temperature reaching 103° on January 23. However, he made
a good recovery and was discharged on February 7 perfectly well, without a
trace of albumin in the urine.
This patient illustrates well certain of the untoward effects of the 
administration of serum. It is probable that if an intradermal skin 
test had been made on admission, the presence of sensitiveness to 
serum would have been detected. As it was, he was incompletely 
desensitized, and he had a mild anaphylactic reaction. This, how­
_ever, was not serious, and that he was completely desensitized 
following it is shown by the absence of reaction after the subseq\lent 
dose. Following.the second large dose of serum there occurred what 
we have termed a thermal reaction. This was unusually severe, but 
very characteristic. It is possible that the following dose of serum 
might have been omitted or at least somewhat delayed, but it is 
better to have erred by giving it too soon than by delaying too long. 
The serum sickness was severe, one of the most severe cases we have 
seen. Repeated and frequent tests of the agglutinating power of 
the patient's. serum were made in this case and, following the :first 
dose of the horse serum, the patient's serum acquired agglutinating 
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power which increased following the second dose, and this increase 
persisted. If we had observed only this case, conclusions as to the 
benefit of the serum would _be difficult. Judging from the fact that · 
the blood culture was positive before the serum w�s given and,that 
the patient was well, as far as the pneumonia was concerned, on the 
6th day, it seems probable that the disease was shortened. In any 
case he recovered, and while the symptoms due to the serum were 
somewhat distressing, they were justified, when the results in the 
whole series of cases are considered. 
Case 2.-I. S., age 32 years (Text-fig. 4). This patient was admitted about 
8 hours following the initial chill. There were defini.te signs of involvement of 
both lower lobes and he presented all the characteristic features of acute lobar 
pneumonia. His temperature on admission was 103.6°F., pulse 120, respirations 
48, leukocytes 35,000. He appeared seriously sick; the blood culture taken on 
admission was positive. Immediately after admission a specimen of sputum was 
injected into a mouse, and the diagnosis of the type of infecting organism, Type 
I, was determined within 12 hours. He was then given his first treatment. 
The temperature at this time was 105.2°, pulse 128, respirations 44. There was 
no immediate reaction following this treatment, but the next morning · the 
temperature was lower, 103.2°, and his general condition was improved. Owing 
to the obviously serious nature of the infection, the treatment was continued very 
. actively, 100 cc. being given at 9 a.m. and 100 cc. at 4.30 p.m. No marked 
reaction followed either of these injections, though after the injection in the 
evening the temperature rose slightly, but fell during the night and was 101 °F. at 
8 a.m. At this time he was very bright; the signs of intoxication had all dis­
appeared. No increase of lung involvement had occurred. In spite of this he 
was watched carefully during the day and, as his temperature was rising, he 
was given another dose of serum. Following this his temperature fell. His 
blood was tested frequently for agglutinatiug power. This, which was negative 
before the first dose of serum, reached a high level immediately following, and 
this level increased with subsequent doses. He also had severe serum sick­
ness, beginning very early, 3 days following the last dose of serum, and last­
ing for a week, with all the symptoms, including joint pains. On the 4th 
day of the serum sickness the temperature reached 103.8°. He made a good 
recovery and was discha_rged on the 24th day of the disease. 
This case well illustrates the importance of early diagnosis and 
treatment. In this case we feel that the treatment was carried out 
in a perfectly satisfactory manner and, except for the serum sickness, 
the results were all that could be hoped for. The administration of the 
fourth dose on the 3rd day, we think, was of great importance in 
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PREVENTION OF PNEUMONIA. 
Epidemiology. 
Lobar pneumonia is generally considered to be an endemic and 
sporadic disease. It is habitually present among the population of 
certain parts of the world, showing, however, certain seasonal varia­
tions in morbidity. In spite of the fact that its incidence may reach 
at times a very high rate, the relation, in origin, of one case to 
another has never been very apparent. Diseases of typical epidemic 
,c;haracter, on the other hand; usually spring from a limited source, 
attain widespread proportions of ten through traceable . channels, 
.and, then, after a limited time, subside, perhaps not to recur again 
for a period of years. Such differences between endemic and epidemic 
diseases, however, probably depend more upon the facility of infec­
tion and the susceptibility of the soil on which the disease is implanted 
than upon any essential difference in the mechanism of communi­
cation. From a public health standpoint, therefore, it is just as 
important to attempt to understand and control the channels of 
communication of an endemic as of an epidemic disease. 
Lobar pneumonia was recognized as a distinct clinical entity in the 
time of Hippocrates. In the 16th and 17th centuries widespread epi-
. demics are reported to have occurred, in which the character of the 
disease seems to have been somewhat different from that observed 
in modern times. In the 19th century pneumonia assumed a defi­
nitely endemic character. At present it is a common infection 
throughout the United States and Canada. It is frequent all over 
temperate Europe, and in the inhabited portions of the south temper­
.ate zone such as Australia, parts of South America, and South Africa. 
Although it is much less frequent in the tropics, it is often seen there 
.among the inhabitants of the plateau regions. Small epidemics in 
limited communities such as military camps, schools, prisons, and on 
shipboard are not of infrequent occurrence, probably due to the inti­
mate contact among individuals which such a life entails. In recent 
86 
AVERY, cmCKERI:NG, COLE, AND DOCHEZ 87 
years two epidemics of more widespread proportions have developed. 
One occurred during the course of construction of the Panama Canal, 
in which the disease affected principally the colored laborers brought 
to the Isthmus from the West Indies. The other took place in the 
Rand Mining District in South Africa. Here, as in Panama, the in­
cidence of the disease was by far the greatest among the black boys 
who were imported from Central Africa to labor in the mines. 
These two epidemics were probably dependent upon the same fac­
tors, the great susceptibility to pneumonia of individuals coming 
from.regions where acute respiratory infections were uncommon and 
the intimate contact dependent upon livipg in common quarters' such 
as barracks and compounds. 
The census of 1900 showed that in the United States somewhat over 
10 per cent of all deaths were'due to some variety of pneumonia; this, 
of course, includes both bronchial and lobar pneumonia, the latter 
being responsible for by far the greater number. Some statistics 
seem to indicate that the incidence of pneu�onia: is increasing. It 
is probable that this apparent increase may be due to better 
methods of diagnosis and recording. One may safely say, however, 
that the incidence of pneumonia has shown no tendency to diminish. 
This may be due in part to the general acceptance of the non-con­
tagious character of lobar pneumonia and the consequent lack of ade­
quate measures of prevention. During the same period of time 
such diseases as diphtheria and tuberculosis have shown a definite 
decrease in morbidity, and one feels inclined to ascribe this shrink­
age to the widespread activity directed toward the limitation of these. 
diseases. It is certain that until the causative factors that operate 
in the continued widespread incidence of lobar pneumonia have been 
brought to light, and until such facts as have been discovered receive 
practical application by Boards of Health, the continued yearly fre­
quency and high mortality of lobar pneumonia will not be checked. 
Pasteur once said t:ka.t it is possible to eradicate all diseases of bac­
terial origin, but that first one must know the bacterial agent and 
record the means by which it establishes itself in the human body. 
In the case of pneumonia, the greatest difficulty that stands in the 
way of obtaining this knowledge is the paradoxical fact that a large · 
proportion of normal individuals may constantly harbor in their 
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mouth secretions organisms which are apparently identical with those 
causing the disease. This situation, however, is ,not characteristic 
of pneumonia alone, for somewhat similar conditions .;i.re found in 
other diseases. For instance, the colon bacillus, an organism not 
far removed from the typhoid bacillus, normally inhabits the intes­
tines of all healthy human beings, and certain cocci resembling the
meningococcus, the cause of cerebrospinal meningitis, are found in the 
mouth secretions of healthy individuals. In these instances it has 
been an easy matter to separate the disease-producing bacteria from 
the more or less harmless saprophytes of normal mucous membranes 
by simple bacteriological methods such as cultural and fermentative 
reactions. The problem in pneumonia, however, has been a much 
more difficult one, since by cultural methods it is impossible to dif­
ferentiate between the more harmless pneumococci and the definitely 
pathogenic ones. However, by the employment of the more specific 
immunity reactions, indications of differences between these two 
general groups of pneumococci have been obtained. 
In view of the fact that a majority of healthy individuals harbor in 
the mouth an organism which has been, until the present time, indis­
tinguishable from the. pneumococcus causing pneumonia, the pre­
sumption has been fairly general that most pneumonic infections are 
to be considered autoinfections and that the important factor in de­
termining the incidence of the disease is variation in susceptibility 
brought about by exposure or other accidental occurrences. If this 
assumption is true, no useful results can be hoped for from the 
usual preventive measures employed in other diseases which are 
designed to limit the spread of the infectious agent. At the Hos­
pital of The Rockefeller Institute (R3, R51, R52) during the past 
few years an attempt has been made to find out whether in reality 
the development of the majority of cases of lobar pneumonia depends 
upon infection with the pneumococcus which the individual habitually 
carries in his mouth secretions, the immediate .onset being caused by 
some factor which temporarily lowers resistance, or whether contact 
infection, either direct or indirect, plays a part of some importance. 
In order to throw light upon this question, the problem has been 
approached from several different points of attack. In view of our 
ability to recognize, by means of specific reactions, definite types of 
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disease-producing pneumococci, it has been deemed important, in 
addition to confirming the constancy of these types, to study also 
the character of the pneumoco'cci present in the normal human 
mouth. In addition to the study of the differences between the 
pneumococci occurring during disease and those in the normal mouth ' 
the character of the pathogenic types has been followed during the . 
disease and convalescence, the time of disappearance from the mouth 
secretions of the pneumococci causing the disease noted, and 
the type of pneumococcus by which they were supplanted studied. 
The mouth secretions of a large number of healthy individuals in 
contact with cases of lobar pneumonia of known type have also been 
studied, in order to determine whether in the mouths of such indi­
viduals 'the disease-producing types of pneumococcus occur with 
greater frequency than in normal mouths and, if so, whether this 
may be attributed to the intimate association, the purpose being to 
detect the existence of actual healthy carriers of pathogenic types 
of pneumococcus. The type of pneumococcus present in the mouth 
secretions of a large number of healthy individuals in whom no his­
tory of contact with lobar pneumonia could be obtained, has also 
been carefully studied. The pneumococcus of the mouth has been 
isolated by injecting a white mouse intraperitoneally with about 0.5 
cc. of saliva, which is a sufficient quantity to kill the animal if pneumo­
coccus is present. The organism has subsequently been isolated in
pure culture from the heart's blood of the mouse and the type deter­
mined by means of the agglutination test.
Types of Pneumococcus in the Mouths of Normal Persons.-In Table 
IX the results of a: study of 297 normal individuals are given, showing 
the percentage of healthy people who habitually carry pneumococcus 
in their mouths, and also a classification of the type of pneumococcus 
found. For purposes of comparison the percentage incidence of the 
different types of pneumococcus _in 454 cases of lobar pneumonia is 
also given (Table X). 
In Table IX is presented the study of the mouth secretions of 297 individuals 
in whom no history of contact with an acute or recent case of lobar pneumonia 
could be obtained. From the mouth secretions of 116 of these individuals pneu­
mococci were isolated, whereas from the mouth secretions of 181 no pneumococcus 
was obtained. Of the 116 individuals carrying pncumococcus in the mouth at 
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TABLE IX. 
Distribution of Dijf erent Typ�s of Pneumococcus in the Mouths of Normal Persons. 
Type of pneumococcus. 
.I. ....................... . 
II ....................... . 
Ila ..................... . 
llb ..................... . 
IIx ..................... . 
III ..................... . 
IV ...................... . 
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the time of observation, the different biologic types of pneumococcus were found 
in the following percentage of instances: Type I was found once, an incidence 
of 0.8 pelf cent; Type II was found not at all; the Subtypes Ila, IIb, and Ilx 
were found 22 times, a percentage incidence of 18.2. Of these Subtype II organ­
isms, Type !Ia is the least common and Type IIx the most frequent. This 
· distribution of the variants of Type II parallels the distribution of the larger,
more inclusive pneumococcus types in the normal mouth. Type III, or Pneu­
mococcus mucosus, was found 34 times, a percentage incidence of 28.1. The
immunologic studies of Type III have shown that this organism is one that shows
little or no variatiori in specificity and in this it corresponds to the typical
pneumococci of Type I and Type II. On the other hand, it presents a paradox
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in that it is frequently found over long periods of time in the mouths of healthy 
individuals and, in spite of this frequency, it is the cause of the smallest number of 
acute cases of lobar pneumonia of the four major types of pneumococci. Type IV 
was encountered in normal saliva 64 times, a percentage incidence of 52.9. 
This type of pneumococcus is therefore the dominant type in the mouth secretions 
of normal individuals. 
Consideration of Table X shows that in a series of ,454 cases of lobar pneu­
monia, Pneumococcus Types I and II was present in 284 instances, a percentage 
incidence of 62.6. The dominance of these two types of organisms in disease 
shows a striking contrast to their almost complete absence in the mouth secretions 
of normal individuals. The · Subtypes !Ia, Ilb, and Ilx were responsible for 
19 instances of disease, 4.2 per cent. Type III pneurnococcus, despite its 
frequent occurrence in the normal mouth, was responsible for but 59 instances of 
disease, 13.0 per cent. Type IV pneurnococcus, the commonest pneumococcus 
present in the bacterial :flora of the normal mouth, was responsible for 92 of the 
cases of lobar pneumonia studied, or 20.3 per cent. 
Comparison of these two tables shows that the pneumococci 
most commonly found in the mouth secretions of normal individuals 
give rise to a minority of the cases of lob,ar pneumonia. The dis­
ease produced by these organisms, with the exception of Type III, 
is less severe in character, indicating a lower grade of pathogenicity 
of these types for man. On the other hand, Types I and II ca.use a 
majority of cases of lobar pneumonia, are of high virulence for human 
beings, and are seldom or never found in the mouth secretions of nor­
mal individuals who have not been in intimate association with cases 
of lobar pneumonia. This seems to indicate that lobar pneumonia 
due to Types I and II does not arise from infection with a pneumo­
coccus which is habitually carried in the mouth, but that infection 
with these organisms occurs from without. 
Types of Pneumococcus in Sputum of Pneu,monia Patients.-1£ all 
cases of lobar pneumonia were due to infection of the individual 
with a type of pneumococcus which was more or less constantly 
present in his mouth secretions, one would expect this organism to 
persist or at least reappear in the sputum after recovery from the dis-
. ease had occurred. Therefore, a study has been made· of types of 
pneumococcus present in the mouth during the disease, as well as those 
present during convalescence. After the type of organism respon­
sible for the disease has disappeared, the type of pneumococcus present 
later has been determined. 
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In Table XI are presented the results of a study in 15 cases. 
These 15 cases are representative and form but a small part of the 
total number of cases studied. 
TABLE XI. 
Persistence during Convalescence of the Type of Pneumococcus Causing_ the Disease.
CaaeNo. Type of pneumococcus during height of disease 
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TABLE XI-Concluded. 
Tzye of pneumococ�us 
Dl\y of dise1i.se on which 
Case No. observation was made, Type of pneumococcus during . during height of disease. reckoned from convl\lescence 
day of initial chill. 




2,,550 III 14 III 
21 IV 





2,640 III 7 No pneumococcus. 
14 " " 
21 " " 
28 " " 
A study of Table XI reveals the fact that only in exceptional instances 
does one find in the sputum for a considerable length of time after 
recovery the same type of pneumococcus. with which the individual 
was infected during the disease. The exact time at which the dis­
ease organisms disappear varies. They have disappeared as early 
as 7 days from the date of onset of the disease, but have been present 
as late as 90 days after recovery. Usually they have disappeared in 
3 to 4 weeks. In a number of instances in which the disease organ­
ism has persisted for an unduly long period of time, delayed resolu­
tion or some chronic respiratory condition has been present. After 
the disease organism disappears, either no pneumococcus is present 
or the disease type has been supplant�d by one of the types which 
are usually found in the saliva of normal individuals. These ob­
servations indicate that the type of pneumococcus responsible for 
lobar pneumonia in any individual is but a temporary and accidental 
inhabitant of his respiratory passages, and, therefore, give addi­
tional evidence that infection occurs from without. They also indi­
cate the length of time that convalescents may be a source of infec­
tion to others in case the mode of infection is by contact. 
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It is seen from Table XI that Type III pneumococcus, which is 
known to occur frequently in the normal mouth, disappears in the 
majority of instances from the mouth flora of cases of pneumonia as 
rapidly as do pneumococci of Types I and II, which induce disease 
more frequently. This suggests that Type III pneumonia may also 
be communicable but that, owing to the frequent occurrence of this 
organism in the normal mouth, th� lines of communication may be 
impossible to trace. 
Pneumococcus Carriers.-Infectious diseases, aside from those 
spread by insects, usually spread by immediate contact, either with a 
person suffering from the disease, or with a convalescent, or with a 
healthy carrier. The importance of these modes of transmission 
varies. with the different diseases and in many instances more than 
one of these mechanisms may be involved. Infection in lobar pneu­
monia by immediate contact with a person ill of the disease undoubt­
edly occurs, and we have seen a number of instances in which this 
mode of infection was apparent]y responsible. With most diseases, 
however, the healthy carrier may be a greater menace to the com­
munity than the infected individual, largely because of failure to 
recognize the carrier condition. In the epidemiology of certain dis­
eases, notably typhoid and· epidemic cerebrospinal meningitis, the 
importance of the carrier state is well recognized. In Table XII 
evide11ce is presented to show that a considerable percentage of per­
sons intimately associated with patients suffering from lobar pneu­
monia harbor in their mouths pneumococci of the same type as those 
causing the disease. The persons who have been studied have been 
relatives · or friends, especially those who have taken care of the 
patients. We have already shown that pneumococci of Types I and 
TABLE XII. 
Incidence of Carrier Condition in Healthy Individuals in Contact with Cases of 
Lobar Pneumonia. 
Type of pneumococcus Total no. of contacts 
No. of positive contacts. In patient. examined. 
� ,em 
I 160 21 13.1 
II 149 18 12.1 
•. 
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II are not found in the mouths of normal individuals not associated 
with cases of pneumonia. 
For purposes of comparison with Table XII, the incidence ofi 
Types I and II in the mouth flora of normal individuals unassociated 
with cases of lobar pneumonia is given (Table XIII). 
TABLE xm.
Incidence of Pneumococcus Types I and II in Saliva of 297 Healthy Itulitiduals 
Not in Contact with Cases of Lobar Pneumo�ia. 









A study of Table XII shows that of 160 healthy individuals in 
contact with cases of lobar pneumonia of Type I, 21, or 13 per 
cent, carried in their mouth secretions at the time of examination a 
pneumococcus of the same type. Of 149 individuals in contact with 
cases of Type II pneumonia, .18, or 12 per cent, were found to carry 
Pneumococcus Type II. When these figures are compared with those 
from 297 healthy individuals not in contact with lobar pneumonia, 
in whom the incidence of Type I pneumococcus was 0.3 per cent and 
that of Type II was 0.00 per cent, very little doubt can be enter-. 
tained that through contact with cases of lobar pneumonia due to 
Type I or Type II pneumococcus, healthy carriers arise with con­
siderable frequency. In almos·t every instance in which a carrier 
of a Type I ·or Type II pneumococcus has been observed, the type 
of organism in the carrier has corresponded with that of the case 
with which he has been associated. Carriers of Type I and Type II 
pneumococcus harbor these organisms in their mouth secretions for 
variable periods of time, the average being from 3 to 4 weeks. At the 
end of this time the disease-producing type usually disapp'ears and 
is replaced, if pneumococci are present at all, by one of the types of 
pneumococcus found in the saliva of individuals who have not been 
in contact with cases of pneumonia. 
Types of Pneumococcus in Dust.-The possible occurrence of pneu­
mococcus in dust has been known for some time. Little signifi.-
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,cance, however, has been attached to this fact: In order to determine 
whether pneumococcus could be recovered with any regularity from 
-dust, and what types are present, Stillman (R52) has carried out the
following study. Specimens of dust were collected as follows: A
piece of paper was wrapped about a small scrubbing brush, this in
tum was covered with a piece of cloth, and the whole sterilized in the
autoclave. The dust of the room to be studied was swept up with
the sterile brush from an area about a foot square. The specimen,
folded in the sterile paper, was taken to the laboratory where it was
mixed with 1 to 1.5 cc. of broth, and �he mixture injected into
the peritoneal cavity of a white mouse. If the animal died cultures
were made from the heart's blood and the type of organism respon­
sible for its death was detennined. In all, 62 specimens of dust from
rooms .in which no case of pneumonia was present were examined.
Pneumococci were recovered from 18 of these specimens, or 29 per
cent, and were absent in 44, or 71 per cent. The frequency of oc­
-currence of the different types· of pneumococcus is shown in Table
XIV.
TABLE XIV. 
Types of Pneumococcus Recovered from Dust of Rooms in Which Lobar Pneumonia 
Had Not Occurred. 
























From Table XIV it is seen that the types of pneumococcus usually 
recovered from the rooms in which healthy individuals are living 
correspond, as one would expect, to those found in the mouth secre­
tions of these individuals. On the other hand, the strictly disease­
p�oducing types of pneumococcus, Types I and II, are not found 
u:p.less possibly a healthy carrier is present� as was the case in the 
one instance given in the table. 
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A similar study was made of the dust of rooms in which cases of 
Type I or Type II pneumonia, had occurred. In all, 183 specimensof dust were examined. In 109 of these . pneumococcus was not 
found. In 7 4 of the specimens of dust pneumococcus was present; 
Table XV gives the distribution of the various types recovered. 
TABLE XV, 
Types of.Pneumococcus Recovered from Dust of Rooms in Which Cases of Lobar 
Pne-umonia Due to Type I or Type II Pneumococcus Had Occurred. 
Type of pneumococcus. Incidence. 
per cefll 
I 25 33.8 
II 23 31.1 
Ila 0 0 
Ilb 2 2.7 
Ilx 2 2.7 
III 2 2.7 
IV 20 27.0 
This study shows that pneumococcus is more frequently present 
in the dust of rooms in which lobar pneumonia has occurred than in 
those in which no pneumonia has existed,and under the former circum­
stances pneumococci of Types I and II are frequently found. More­
over, in these instances the type of pneumococcus found in the dust 
corresponded with the type of pneumococcus causing the disease. 
Conclusions Regarding Epidemiology.-When all these observations 
are taken together, we have considerable evidence, contrary to the 
opinion pre�ously held, that pneumonia, in a considerable propor­
tion of the cases at least, arises by infection from without. This evi­
dence relates mainly to the cases due to infection with Type I or 
Type II pneumococcus, which organisms, however, are responsible for 
over 60 per cent of the cases. Pneumococci of these types persist for 
a limited time only in the mouths of patients who have suffered from 
the disease, and are very rarely, if ever, present in the mouths of 
normal persons who have not been in immediate contact with such 
patients. Pneumococci are not infrequently found in dust, but those 
of Type I and Type II are practically never found except in the en­
vironment of persons sick of the disease or in the environment of 
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carriers. Possible sources of infection of those who acquire infection 
with pneumococci of these types, therefore, are other patients suffer­
ing from pneumonia due to the same type of pneumococci, persons 
who carry these organisms during convalescence, persons who have 
acquired the organisms by close contact with patients (healthy 
carriers), and dust from the immediate environment of patients or 
carriers. 
We therefore now have evidence in regard to the mode of infe'ction 
in pneumonia of these two types which affords a justifiable basis for 
instituting preventive measures. The conditions in regard to the 
other types of pneumonia are not yet sufficiently well known to justify 
discussion here. 
General Preventive Measures. 
If lobar pneumonia in a large percentage of instances is readily 
communicable from one individual to another, as the evidence given 
above seems to indicate, it is clea� that public health authorities 
should take cognizance of this fact in their efforts to limit the wide­
spread incidence and high mortality of this disease. Even if accu­
rate knowledge of the exact mode of transmission were unknown, the 
enforcement of such precautions as are taken in the effort to control 
the spread of tuberculosis, epidemic cerebrospinal meningitis, and 
diphtheria. would be justifiable. Since we have definite knowledge 
concerning the mode of transmission in a large percentage of the 
severe cases of lobar pneumonia, it is extremely important that these 
, precautionary steps should be taken. 
One of the essential measures for the success of a campaign against 
any communicable disease is to provide the public with all the avail­
able knowledge concerning it and to explain the dangers that each 
infected individual presents to those with whom he comes in con­
tact. The first step, therefore, in the control of lobar pneumonia 
would seem to be the institution of an educational campaign·, so that 
the public mind may be receptive to such measures of control as 
may be deemed necessary. 
In order that public health boards may institute the measures 
nec�ssary for the control of an epidemic disease, it has been found 
essential that they should obtain knowledge of the incidence of the 
' 
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disease in a locality, and of the focal. distribution of the cases. 
The only means by which this knowledge can be acquired is through 
compulsory notification. Certain Boards of Health now have regula­
tions requiring notification of cases of lobar pneumonia, but these are 
rarely enforced, and at present the incidence of this disease can only 
.. be approximately determined by calculation from the mortality sta­
tistics. Such a measure would not, in all probability, meet with 
public opposition, as has developed from the attempt to bring 
about compulsory notification of tuberculosis or venereal disease. 
Because of the ease and rapidity with which· the diagnosis of lobar 
pneumonia is made by the practitioner, the statistics obtained would 
probably be quite accurate. In view of the fact that only certain 
types of lobar pneumonia have been shown to be communicable, 
public health laboratories should be equipped to determine the type 
of pneumococcus responsible for each particular case of the disease. 
Additional data concerning the epidemiology of the disease would 
then be available. 
Each case of pneumonia should be regarded as a focus for the spread 
of the infection and the care of each· patient should include those · 
measures which have been found serviceable in other communicable 
diseases. The patient should be isolated as far as possible and his 
communication with other individuals should be reduced to a practi­
cal minimum. Inasmuch as the pneumococcus finds its way to the 
outside world mainly in the secretions from the buccal and respira­
tory tracts, the sputum should be collected in special containers 
and either burned or disinfected. All utensils, handkerchiefs, bed 
clothing, etc., which are likely to become contaminated through ' contact with the mouth or otherwise should be sterilized before 
again being put into general use. 
The studies of Stillman have shown that a large percentage of 
pneumonia patients contaminate the rooms which they occupy, as is 
shown by the large number of instances in which strictly pathogenic 
types of pneumococcus can be recovered from the dust of these 
apartments. This indicates the necessity for thorough cleansing of 
any room occupied by a case of pneumonia at the close of the period 
of convalescence. In addition, the daily cleansing of the sick room
should be practised in such a way as to avoid dissemination of dust
narticles. 
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From the studies presented above it is seen that tw(1 types 
of carriers of ,pathogenic pneumococci exist: first, convalescents 
from the disease, and second, healthy individuals who have not 
contracted the disease themselves, but who have been in intimate 
association with cases of the disease. These individuals usually carry 
the pathogenic pneumococci for 3 to 4 weeks, but instances have 
been observed in which the pneumococci have been harbored in 
the mouth secretions for much longer periods. The control of healthy 
carriers of disease-producing bacteria is one of the most difficult and 
perplexing problems in the regulation of infectious diseases, and one 
which has not as yet been satisfactorily solved. The ideal method 
· would be to isolate and limit the contact of carriers until they
no longer harbor the organisms of disease. Such a procedure un­
fortunately is not always practicable. In any case carriers of the
strictly disease-producing types of pneumococci should be instructed
to avoid promiscuous spitting, they should be told to refrain from
kissing, and they should be instructed in the proper methods of
disposing of any sputum or expectoration. Disinfecting mouth
washes have proved of some advantage in eliminating the organisms
from the nasopharyngeal secretions of meningococcus carriers, and
it is possible that a similar method may prove of service in shorten­
ing the period of time in which convalescents from lobar pneumonia
or pneumococcus carriers harbor the pathogenic organisms in the
mouth. This procedure has not yet been carefully tried. In con­
valescents it is not likely to prove of great value, however, because
the pneumococci are probably present in the deeper air passages not
reached by the disinfectant.
It is well known that epidemics of lobar pneumonia often arise
and attain considerable proportions in small communities in which
people live in close association with one another, such as military
barracks, labor compounds, schools, asylums, hospitals, prisons, etc.
It is under these conditions that the preventive measures described
above should prove of the greatest value. In the control of an
epidemic disease it is necessary that prophylactic measures should
-oe· instituted coincidently with the development of _the .first cases,
in order to prevent the wide dissemination of the virus and the con­
sequent failure of all precautionary methods. Therefore, upon the
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outbreak of pneumonia in such communities as military barracks, 
all patients should be immediately isolated, their contact with 
other individuals cut off, and a search for carriers of the diseas�­
producing types of pneumococcus made among their associates. 
The carriers found should be isolated, or at least made as harmless. 
as possible, by instituting the measures mentioned above. It is. 
only in this way that the distribution of the pneumococcus <1,nd the 
·resulting high prevalence of pneumonia can be prevented.
Prophylactic Vaccination. 
Animal experiments have shown that it is very easy to produce 
active immunity to pneumococci by the injection of small doses of 
dead organisms, even in animals as susceptible as the mouse and 
rabbit, and this immunity persists for a considerable time. It is. 
theoretically possible, therefore, to immunize men to the fixed types. 
of pneumococci by the injection of dead cultures. The advisability 
of doing this in a civilian population under ordinary conditions has. 
never been seriously considered. There are undoubtedly mark,edi 
differences in th� susceptibility of individuals to pneumococcus in­
fection, just as there are differences among individuals in susceptibility 
to diphtheria. The so called Schick test has made the detection of 
individuals who are immune to diphtheria possible. If a similar­
method were applicable in pneumonia, so that persons either sus.--: 
ceptible or immune to pneumococcus infection could be readily de­
termined, the number whom it would be necessary to immunize could 
be greatly reduced, and probably the immunization of the entire 
population against infection, with certain types of pneumococci at 
least, would be both practical and possible. 
Even in the absence of methods of differentiating the susceptible 
individuals from the immune, ho:wever, whenever pneumonia exists to 
an extraordinary degree among certain groups of individuals, and in 
the case of epidemics, the question of preventive inoculation should be 
considered. The only place, to our knowledge, where this has· been 
attempted on a large scale has been among the workers in the mines. 
in South Africa, where the disease prevails to a most alarming de­
gree an� causes the death of very large numbers of na,tive workmen .. 
These efforts were made during 1911 and 1912 under the direction of 
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Sir Almroth Wright (35). In spite of the many conclusions and 
hypotheses presented in the elaborate report of this work, no definite 
results as to the efficacy of the procedure were obtained. No 
effort was made to immunize the men against the different specific 
types of pneumococci; indeed no attention was paid to differences 
in type, and it is therefore evident that the work could only re­
sult in confusion. Later Lister (9, 10) carried on experimental 
studies in the South African Institute for Medical Research, both on 
.animals and man, and established certain facts which may go far in 
making this method of prevention of pneumonia one of great value . 
. He first determined the types of pneumococci causing the prevailing 
pneumonia, and learned that, in addition to the types found in Europe 
.and the UI½ted States,. at least one additional type exists, which is 
-0ne of those most frequently encountered there. He then studied the
production of active immunity to these various types in animaJs,
and also investigated for the first time the best method of producing
immunity in man. He has found that it is easier to produce immunity
by intravenous than by subcutaneous injection. However, by the
injection of. sufficiently large doses of vaccine he has, been able to pro­
duce immunity in man by subcutaneous injection. The tests of
immunity employed consisted in demonstrating the presence of ag­
glutinins and opsonins in the blood. It may be objected that these
methods do not necessarily indicate active immunity. However, as
far as animal studies may be applicable, it has been the experience of
.all investigators that animals whose blood contains these antibodies
.are always actively immune. We therefore believe that these tests
.are perfectly justifiable and reliable in judging of the presence of 
.active immunity. As we have stated elsewhere, estimations of pro­
tective power probably give more accurate quantitative indications of
immunity, but in the present circumstance such great accuracy is not
jmportant. From Lister's studies he concluded that for prophylactic
purposes "three subcutaneous inoculations, at 7 days' jnterval,
.ghould be employed; each dose should consist of 6,000 million cocc;i
,of each group against which immunity is desired." He found that 8
months after the last inoculation his own serum still contained
.agglutinins and opsonins against the types of organisms injected.
Re has found that the reactions following the injection of even
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very large doses of vaccine are slight. Our experience fully bears 
this out. These observations of Lister are of great · value and 
importance. Our studies on the production of immunity in animals 
-(R31), however, suggest strongly that more effective and rapid im­
munity may be produced by the frequent injection of small amounts 
of vaccine than by the infrequent injection of large amounts. Such a 
method of immunization, however, involves practical considerations, 
the discussion of which cannot be entered into here. The important 
fact is that active immunity may be produced against the specific 
types of pneumococci and that this immunity persists for a con­
siderable length of time. The question of the advisability of active 
immunization against pneumonia is now a very acute and important 
one, since within a short time large numbers of susceptible men will 
be collected together in soldiers' camps, and it is probable that, unless 
preventive measures are instituted, large numbers of them will be 
attacked by the. disease. Before preventive inoculation is undertaken 
on a large scale, certain questions must be answered: Is it justifiable 
or practicable to subject large numbers of men to the resulting 
inconvenience and loss of time in the hope of protecting a number 
of them from this serious disease? If this method is employed, how 
may the highest grade of immunity be produced, what should be the 
size of the dose, the site of injection, the frequency and nwnber of 
injections, and what is the best form of antigen to be eJl?.ployed? 
A number of these problems are now being studied. The results of 
such a method of prophylaxis cannot, .of course, be foretold with 
accuracy. We can only say that as far as experiments on animals 
are of value, the employment of this method would result in great 
saving of human life. A trial· of this method in army camps has 
already been strongly recommended by Major Nichols (18) of the 
United States Army. 
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